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Cullin/RING ubiquitin ligases (CRL) comprise the largest subfamily of ubiquitin ligases.
CRLs are involved in cell cycle regulation, DNA replication, DNA damage response (DDR),
development, immune response, transcriptional regulation, circadian rhythm, viral infec-
tion, and protein quality control. One of the main functions of CRLs is to regulate the DDR,
a fundamental signaling cascade that maintains genome integrity. In this review, we will
discuss the regulation of CRL ubiquitin ligases and their roles in control of the DDR.
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INTRODUCTION
Our genome is under constant attack by exogenous DNA insult-
ing agents, such as UV light and chemical carcinogens, and by
endogenousmetabolicproducts,suchasreactiveoxidativespecies.
In order to prevent genome instability, a hallmark of cancers,
eukaryoticcellshaveevolvedseveralprotectivemechanismsof the
DNAdamageresponse(DDR),includingDNAreplicationandcell
cycle arrest,and DNA repair initiation (Harper and Elledge,2007;
Negrini et al.,2010). During a DDR,cascades of phosphorylation
eventsareinitiatedbyafamilyofPI3-likefamilykinases,mainlyan
ataxia telangiectasia mutated (ATM), and ATM and Rad3-related
(ATR) kinases (Harper and Elledge, 2007; Negrini et al., 2010).
Recent studies, however, have indicated that ubiquitination also
playsimportantrolesintheDDR(HarperandElledge,2007;Mes-
sick and Greenberg, 2009; Negrini et al., 2010; Silverman et al.,
2012).
Ubiquitinisan8-kDaproteinandcanbecovalentlyconjugated
to other proteins via an isopeptide linkage between its C-terminal
glycine and a primary amino group of its substrates, which is
usually from a lysine side chain (Pickart, 2004; Hannah and
Zhou,2009).Ubiquitinationiscatalyzedbythreeenzymes,includ-
ing a ubiquitin activating enzyme (E1), a ubiquitin conjugating
enzyme (E2), and a ubiquitin ligase (E3) (Pickart, 2004; Hannah
and Zhou, 2009). The ubiquitination machinery can conjugate a
single ubiquitin to one lysine residue of substrates (called mono-
ubiquitination), multiple single ubiquitin molecules to multiple
lysine residues (called multi-ubiquitination), or multiple ubiqui-
tins in a chain (called poly-ubiquitination) to substrates. Mono-
ubiquitination and multi-ubiquitination play important roles in
endocytosis, DNA repair, immune response, and transcriptional
regulation, etc. Poly-ubiquitination via surface lysine residues of
ubiquitin, such as Lysine-48 (K48) or Lysine-11 (K11) often leads
to protein proteolysis through the 26S proteasome (Pickart,2004;
Pickart and Eddins, 2004). However, protein poly-ubiquitination
does not necessarily drive protein turnover. Poly-ubiquitin chains
viaLysine-63residue(K63)of ubiquitinandlinearpoly-ubiquitin
chains appear to play non-proteolytic functions and are involved
in DNA repair,NF-κB activation,and Ras localization and signal-
ing, etc. (Pickart, 2004; Jura et al., 2006; Yan et al., 2009, 2010; Xu
et al.,2010).
The human genome contains two E1 with distinctive functions
(Chiu et al., 2007; Jin et al., 2007; Pelzer et al., 2007; Lee et al.,
2011), dozens of E2s and hundreds of E3 ligases which deter-
minethespeciﬁcityofsubstratesforubiquitination(Pickart,2004;
Pickart and Eddins, 2004). Thus far, more than 600 ubiquitin lig-
ases have been identiﬁed in the human genome, although many
of them have not been linked to any substrates or biological activ-
ities. Based on their domain characteristics, ubiquitin ligases can
be separated into two sub-groups, HECT domain E3 ligases and
RING ﬁnger domain E3 ligases (Pickart, 2004). The cullin/RING
ubiquitin ligases (CRL) comprise the largest subfamily of RING
ﬁnger-containing E3s (Petroski and Deshaies, 2005; Sarikas et al.,
2011).CRLsaremodularubiquitinligases(PetroskiandDeshaies,
2005; Sarikas et al., 2011). CRLs are involved in cell cycle regu-
lation, DNA replication, DDR, development, immune response,
transcriptional regulation, circadian rhythm, viral infection, and
protein quality control (Petroski and Deshaies,2005). This review
will focus on the interplay between human CRL ubiquitin ligases
andtheDDR.Wewilldiscussmolecularfeaturesof CRLsandhow
theyparticipateintheDDRbytargetingDDR-regulatoryproteins
for ubiquitination.
INTRODUCTION OF CRL UBIQUITIN LIGASES
Cullin/RING ubiquitin ligases consist of multiple subunits (Pet-
roski and Deshaies, 2005; Sarikas et al., 2011), including a RING
ﬁnger protein (Rbx1 or Rbx2) that recruits an activated ubiquitin
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E2 enzyme, a scaffold subunit (cullin family proteins), and a sub-
strate receptor that recognizes substrates. Many CRL ubiquitin
ligases contain additional linker proteins, such as Skp1 in SCF
(also called CRL1) and DDB1 in CRL4 (Figure 1). Recent studies
indicatethatRbx1associateswithallcullins,exceptforCul5,which
associates speciﬁcally with Rbx2 (Kamura et al., 2004; Huang
et al., 2009), suggesting distinct roles of the two Rbx homologs
in human.
The ﬁrst CRL E3 ligase, named SCF complex (stands for
Skp1/Cdc53 or cullin/F-box), was identiﬁed from budding yeast,
Saccharomycescerevisiae (Baietal.,1996;Willemsetal.,1996;Feld-
manetal.,1997;Skowyraetal.,1997;Vermaetal.,1997).Thisﬁnd-
ing initiated with studies of proteasome-dependent turnover of
Sic1, an inhibitor of cyclins and cyclin-dependent kinases (Cdks)
in budding yeast (Bai et al., 1996; Willems et al., 1996; Feldman
et al., 1997; Skowyra et al., 1997;Verma et al., 1997). Degradation
and ubiquitination of Sic1 at the G1/S transition were compro-
misedinCdc4,Cdc53(Cul1homologinyeast),andSkp1mutants
in budding yeast, which suggested their common roles in Sic1
turnover (Bai et al., 1996; Feldman et al., 1997; Skowyra et al.,
1997; Verma et al., 1997). The ubiquitination function of Cdc53
was observed in yeast Cln2 stability control as well (Willems et al.,
1996). Biochemical evidence demonstrated that Cdc53 functions
together with Cdc4 and Skp1 as a ubiquitin ligase (SCFCdc4)t o
catalyze the poly-ubiquitination of Sic1 both in vitro and in vivo
(Feldman et al.,1997; Skowyra et al.,1997). Within the SCF com-
plex,Cdc4,theF-boxprotein,isasubstratereceptorthatrecognizes
Sic1 within its WD-40 motif and interacts with Skp1 through its
F-boxdomain.Skp1isthelinkerproteinthatmediatesassociation
of Cdc4 with the scaffold cullin protein, Cdc53. Rbx1 (also called
ROC1 or Hrt1 in yeast), a RING ﬁnger protein in the complex,
was found to regulate the stability of yeast Sic1, human HIF1α,
and other substrates (Lyapina et al., 1998; Kamura et al., 1999;
Ohta et al., 1999; Seol et al., 1999; Skowyra et al., 1999; Tan et al.,
1999). Structurally,Rbx1 binds to the C-terminal domain of yeast
Cdc53 or human Cul1, and an E2 enzyme, Cdc34 (Zheng et al.,
2002b; Zimmerman et al., 2010; Duda et al.,2011).
REGULATION OF CRL UBIQUITIN LIGASES
The activity of CRL ubiquitin ligases is regulated by NEDD8, a
small ubiquitin-like protein (Deshaies et al., 2010). Like ubiqui-
tin,NEDD8 can be conjugated to other proteins,especially cullins
(Xirodimas et al., 2004; Watson et al., 2006; Jones et al., 2008).
FIGURE 1 |Architecture of CRL1 (SCF) and CRL4 ubiquitin ligases. SCF
ubiquitin ligases contain Cul1, Rbx1, Skp1, and F-box proteins which
function as substrate receptors; whereas CRL4 has Cul4, Rbx1, DDB1, and
DCAF proteins as substrate receptors. Both SCF and CRL4 can be activated
by neddylation. F-box and DCAF proteins are substrate speciﬁcity factors.
The conjugation of NEDD8, named neddylation, is catalyzed by
NEDD8-speciﬁc E1, E2, and E3 (Dye and Schulman, 2007). The
general consensus is that neddylation of cullins is required for
activation of CRL ubiquitin ligases. However, untimely neddyla-
tion of cullins could drive destruction of substrate receptors via
auto-ubiquitination (Cope and Deshaies, 2006). Therefore, the
neddylation of cullins is counteracted by the deneddylation activ-
ity of a multifunctional protein complex, the COP9 signalosome
(CSN)(CopeandDeshaies,2003;SerinoandDeng,2003;Weiand
Deng, 2003;Wei et al., 2008).
COP9 signalosome was initially found to be involved in plant
photo morphogenesis and was later identiﬁed as a conserved
complex in eukaryotes (Cope and Deshaies, 2003; Serino and
Deng, 2003; Wei and Deng, 2003; Wei et al., 2008). CSN is com-
prised of eight subunits,which are CSN1–8 in order of decreasing
molecular weight. The CSN complex participates in multiple bio-
logical events, including transcriptional regulation, cell division,
and development,etc. (Tateishi et al.,2001; Lykke-Andersen et al.,
2003; Panattoni et al., 2008). Part of the multi-functionality of
CSN is linked with the neddylation system, with its isopeptidase
activitytoremoveNEDD8conjugation.Thisdeneddylationactiv-
ity is attributed to the metalloprotease motif of CSN5 but the
whole CSN complex is required for the reaction (Cope et al.,
2002). Indeed, conditional silencing of CSN5 in HEK293 cells
increased the neddylation of cullins. Consequently, expression
of multiple F-box proteins, but not the cullins, was decreased
(Cope and Deshaies,2006). The reduced expression of F-box pro-
teins depends on Cul1 and the proteasome,further supporting an
auto-ubiquitination and self-destruction mechanism (Cope and
Deshaies, 2006). These data explain why accumulation of CRL
substrates has been observed in cells where either CSN or the
NEDD8 conjugation system is inactivated (Tateishi et al., 2001;
Lykke-Andersen et al., 2003; Cope and Deshaies, 2006; Panattoni
et al., 2008; Choo et al., 2011). It is clear that expression of some
substrate receptors is not affected by neddylation, however (Cope
and Deshaies,2006).
Neddylation of cullins positively regulates the E3 ligase activ-
ity of CRLs by at least three mechanisms. First, neddylation of
cullins enhances their interaction with ubiquitin-activated E2. It
hasbeensuggestedthatneddylationof Cul1canincreasetheafﬁn-
ity between ubiquitin-activated E2 and Rbx1 (Kawakami et al.,
2001). Using ﬂuorescence resonance energy transfer (FRET) tech-
nology, Saha and Deshaies (2008) observed that neddylation of
Cul1 can enhance Cdc34 binding to SCF ubiquitin ligase.
Second, neddylation positively regulates the ubiquitination
activityofCRLubiquitinligasesbyenhancingubiquitintransferto
substrates from the active E2 site and by positioning the active E2
site closer to ubiquitin accepting sites of substrates. Neddylation
has been shown to stimulate the Cdc34-dependent ubiquitination
activity of SCF by more than 10-fold (Saha and Deshaies, 2008).
Theκcat forubiquitintransferisenhancedbyNEDD8conjugation
(Saha and Deshaies,2008). According to the structural analysis of
the SCFSkp2 ubiquitin ligase,Cul1 holds the Skp1–Skp2 and Rbx1
subunitsmorethan100Åapart(Zhengetal.,2002b).Agapof50Å
between the active cysteine of E2 and the leucine-rich repeat of
Skp2 exists even after E2 joins SCFSkp2 (Zheng et al.,2002b). This
gapwasconﬁrmedbyadditionalSCFstructuralstudies(Wuetal.,
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2003; Hao et al., 2007). In these scenarios, a gap of ∼5 0Åi st o o
largeforE2totransferubiquitintoitssubstrates.Theneddylation
of cullins, however, induces conformational changes in both the
N-terminal and the C-terminal domains of cullins (Duda et al.,
2008). These conformation changes make Rbx proteins acquire
more ﬂexibility to get access to their substrates. Such conforma-
tional rearrangements remain even after deneddylation, allowing
both initiation and elongation of poly-ubiquitin chains.
Third,cullin neddylation prevents CRLs from associating with
CAND1, a negative regulator of CRLs (Liu et al., 2002; Zheng
et al., 2002a; Hwang et al., 2003; Min et al., 2003; Oshikawa et al.,
2003; Goldenberg et al., 2004). The binding of CAND1 to cullins
obscures their associations with their substrate receptors, which
results in the inactivation of CRL E3 ligases. CAND1 only asso-
ciates with non-neddylated cullins. Therefore, the popular model
is that cullin neddylation favors the dissociation of CAND1 from
CRLs. NEDD8-conjugated CRLs, which are free of CAND1, pos-
sess maximal E3 activity. After deneddylation by CSN, CAND1 is
able to inhibit CRLs by binding to cullins. The next neddylation
cyclecanthenpreventCAND1frombindingandCRLactivitywill
resume. However, a recent study from the Harper group revealed
that only a small fraction of cullins is associated with CAND1,
whereas the majority of Cul1 proteins form complexes with F-box
proteins, the substrate receptors (Bennett et al., 2010). There-
fore, at least for the SCF ubiquitin ligases, the formation of SCF
complexes is driven mainly by receptor binding.
Neddylation is catalyzed by its E3 ligase, Rbx (Huang et al.,
2009).RecentstudiesindicatedthattheDCNfamilyproteinsfunc-
tion as additional E3 ligases to assist Rbx in cullin neddylation
(Kurz et al., 2005, 2008; Ma et al., 2008; Meyer-Schaller et al.,
2009). Wu et al. (2011) found that human DCN1 is modiﬁed by
mono-ubiquitination,which drives nuclear export of DCN1. The
biologicalimpactofmono-ubiquitinationofDCN1underphysio-
logicalconditionremainstobedetermined,however.Interestingly,
expression of DCN3L, a human homolog of yeast Dcn1p, can be
enhanced by UV light (Ma et al., 2008), suggesting that the DNA
damage signal may enhance neddylation of some, if not all, CRL
ubiquitin ligases that are important for DDR.
The CRL family is one example of ubiquitin ligases that medi-
ate many cellular signaling events (Petroski and Deshaies, 2005).
In the following sections, we will discuss the roles of individual
CRL ubiquitin ligases in control of DDR.
SCFβTRCP IN DNA DAMAGE CHECKPOINT CONTROL
SCFβTRCP IN DDR-INDUCED Cdc25A UBIQUITINATION AND TURNOVER
Cdc25A is a dual phosphatase that targets phosphory-
lated tyrosines and serines/threonines for de-phosphorylation
(Karlsson-Rosenthal and Millar, 2006; Ray and Kiyokawa, 2007,
2008; Rudolph, 2007). Removal of inhibitory phosphate on tyro-
sinebyCdc25Aactivatescyclin/Cdkkinases,mainlycyclinE/Cdk2
and cyclin A/Cdk2, and enables the G1/S transition and mitotic
entry. Cdc25A has two close homologs, Cdc25B and Cdc25C. It
wasproposedthatCdc25BinitiatestheactivationofcyclinB/Cdk1
and Cdc25C completes this process in the nucleus during the
G2/M transition (Boutros et al., 2006). However, both Cdc25B
and Cdc25C are dispensable in mouse development, except for
meiosis (Chen et al., 2001a; Ferguson et al., 2005). Cdc25B and
Cdc25C double knockout mice are viable, but females are ster-
ile, as are Cdc25B knockout females (Ferguson et al., 2005). In
contrast, Cdc25A is essential for early embryo development (Ray
et al., 2007a). In summary, Cdc25A is an essential gene for mouse
development and is one of the major regulators of cell division
(Molinari et al., 2000; Zhao et al., 2002; Ray and Kiyokawa, 2007,
2008). The Cdc25A protein level is tightly regulated via transcrip-
tionandproteasomedegradationinacellcycle-dependentmanner
(Ray and Kiyokawa,2007).
Over-expressionof Cdc25Ahasbeenobservedinmultiplecan-
cers (Kristjánsdóttir and Rudolph, 2004; Boutros et al., 2006).
Studies in Cdc25A knockout mice indicated that Cdc25A is a
rate-limitingoncogenethatrestrictstumorigenesisinducedbythe
HER2/neu–RASoncogenicpathway(Rayetal.,2007a).Consistent
with this observation, MMTV-Cdc25A transgenic mice dramati-
cally promote murine mammary tumorigenesis in cooperation
with oncogenic RAS or neu (Ray et al., 2007b). Over-expression
of Cdc25A in human cells can result in aberrant mitotic events,
compromised DDR and destabilized chromosomes,such as chro-
mosomal breaks at fragile sites (Cangi et al., 2008). Therefore, it
is critical to maintain appropriate amounts of Cdc25A in human
cells.
Cdc25A is an unstable protein and its protein levels are medi-
ated by phosphorylation and the ubiquitin–proteasome pathway
(Bernardi et al.,2000; Mailand et al.,2000,2002; Falck et al.,2001;
Donzelli et al., 2002, 2004; Shimuta et al., 2002; Zhao et al., 2002;
Busino et al., 2003; Goloudina et al., 2003; Jin et al., 2003, 2008;
Sørensen et al., 2003; Xiao et al., 2003; Kasahara et al., 2010).
In response to DNA damage, Cdc25A is phosphorylated by the
checkpointkinase,Chk1,andsubjectedtoproteasome-dependent
degradation (Zhao et al., 2002; Goloudina et al., 2003; Jin et al.,
2003; Sørensen et al.,2003; Xiao et al.,2003; Donzelli et al.,2004).
The consequence of Cdc25A turnover is persistent Cdk phospho-
rylation and cell cycle arrest at S-phase upon DDR (Busino et al.,
2003; Jin et al., 2003). IR-induced Cdc25A turnover in interphase
was shown to depend on Cul1, suggesting the involvement of the
SCFE3ligase(Donzellietal.,2002).Inascreentoidentifythesub-
strate receptor of the SCF complex, the F-box proteins, βTRCP1
and βTRCP2, two homologs of human βTRCP, were found to
be interacting with Cdc25A. Knockdown of both βTRCP1 and
βTRCP2 by siRNA or expression of a dominant-negative βTRCP1
blocked DDR-induced Cdc25A proteolysis (Busino et al., 2003;
Jin et al., 2003). In addition, depletion of both βTRCP1 and
βTRCP2 results in hyperactive Cdk2 kinase activity and radio-
resistant DNA synthesis, which are characteristics of a defective
intra-S-phase checkpoint (Busino et al.,2003; Jin et al., 2003).
Therecognitionof ubiquitinsubstratesbyF-boxproteinsoften
requirespost-translationalmodiﬁcation,usuallyphosphorylation,
on target proteins (Petroski and Deshaies, 2005). Chk1 kinase
activity is indispensible for in vitro ubiquitination of Cdc25A cat-
alyzed by SCFβTRCP (Jin et al., 2003). Upon DDR, the Serine-296
(S296) site of Chk1 is autophosphorylated after it is phosphory-
lated at Serine-345 (S345) by ATR (Kasahara et al., 2010). Chk1
phosphorylated at S296 is further recognized by 14-3-3 gamma.
14-3-3 gamma not only tethers Chk1 in the nucleus, but also
bridgestheinteractionbetweenChk1andCdc25A(Kasaharaetal.,
2010). Therefore,14-3-3 gamma is important for Chk1-mediated
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Cdc25A turnover via the ubiquitin–proteasome pathway (Kasa-
hara et al., 2010). Several Chk1 phosphorylation sites on Cdc25A
were mapped, but only mutation on Serine-76 (S76) abolishes
Cdc25A ubiquitination (Jin et al., 2003, 2008). Surprisingly, pep-
tide scanning and mutagenesis revealed that S76 alone was not
sufﬁcient for direct binding with βTRCP (Jin et al., 2003). Adja-
cent to S76, there is a DSGFCLDSP sequence (residues 81–89)
whichresemblestheclassicphospho-degronmotifinotherβTRCP
substrates (Cardozo and Pagano, 2004). Serine-88 is dispensable
for SCFβTRCP-mediated Cdc25A ubiquitination (Jin et al., 2003).
Although Aspartic acid-87 could mimic a phosphorylated-serine,
it appears not to be involved in binding of Cdc25A to βTRCP (Jin
et al.,2003). Phosphorylation of both Serine-79 (S79) and Serine-
82 (S82) is required for Cdc25A ubiquitination (Jin et al., 2003).
In addition, the phospho-S79 and phospho-S82 peptides are able
to bind to βTRCP in vitro, indicating these two sites are central
to where βTRCP recognizes Cdc25A (Jin et al., 2003). Chk1 can
phosphorylate neither S79 nor S82, however. Therefore, it seems
that active Chk1 phosphorylates S76 of Cdc25A in response to
DNA damage, which creates a priming site for additional kinases
to subsequently phosphorylate S79 and S82 residues. Phosphory-
lation of these residues recruits SCFβTRCP to ubiquitinate Cdc25A
for turnover (Figure 2).
Besides Chk1, another checkpoint kinase Chk2 plays an
important role in DDR-induced Cdc25A degradation (Falck
et al., 2001). Chk2 has been found to phosphorylate Serine-124
(S124) of human Cdc25A, which is important for IR-induced
Cdc25A turnover. Compared to S76, however, S124 phospho-
rylation appears to play a minor role in DDR-induced degra-
dation of Cdc25A (Jin et al., 2003). Moreover, Chk2 can not
phosphorylate S76 of Cdc25A in vitro efﬁciently (Jin et al.,
2008). These data may explain why deletion of Chk2 in HCT116
cells has no impact on IR-induced Cdc25A turnover (Jin et al.,
2008). This further emphasizes the primary importance of Chk1
phosphorylation at S76 in control of Cdc25A under DDR.
The discrepancy in the role of Chk2 in DNA damage-induced
Cdc25A degradation may depend on cell types and different
DNA damage signals. Further studies are needed to resolve this
issue.
FIGURE 2 | Multiple kinases lead to the formation of phospho-degron
of Cdc25A under DDR. Under DDR ATR activates Chk1 which then
phosphorylates Cdc25A at S76 and turns on NEK11. Consequently, NEK11
phosphorylates Cdc25A at S82, whereas, CK1α phosphorylates both S79
and S82 of Cdc25A. In p53-deﬁcient cells, p38MAPK and MK2 lead to the
phosphorylation of S76 under UV damage. Upon the phospho-degron is
created, Cdc25A is recognized and ubiquitinated by the SCF
βTRCP ubiquitin
ligase.
In addition to Chk1 and Chk2, other protein kinases are
involved in Cdc25A proteolysis in unsynchronized or stressed
c e l l sa sw e l l( Reinhardt et al., 2007; Kang et al., 2008; Melixet-
ian et al., 2009; Honaker and Piwnica-Worms, 2010; Myer et al.,
2011; Piao et al., 2011). In p53-deﬁcient cells, Cdc25A proteol-
ysis depends on p38 MAP kinase (p38MAPK), and MAPKAP
Kinase-2 (MK2), but not Chk1 (Reinhardt et al., 2007). Appar-
ently, Chk1 and MK2 recognize similar phosphorylation motifs,
such as the one surrounding S76 of Cdc25A (Reinhardt et al.,
2007). In this case, p38MAPK and MK2 mediate a third DNA
damage checkpoint pathway for cell cycle arrest and survival after
DNA damage, although an intact ATR–Chk1 pathway exists in
p53-deﬁcient cells (Reinhardt et al., 2007). Therefore, p38MAPK
and MK2 are potential candidates for drug targets to kill cancer
cells that are defective in p53 function. However, how p53 affects
the selection of checkpoint pathways in Cdc25A proteolysis has
yet to be determined.
Chk1 and SCFβTRCP mediate Cdc25A turnover in the S and
G2 phases of cell division. At late G1-phase, Cdc25A stability
is not controlled by Chk1, although Cdc25A ubiquitination is
still SCFβTRCP-dependent. Kang et al. (2008) found that GSK3β
phosphorylates S76 of Cdc25A at late G1-phase. Interestingly,S76
phosphorylation requires prior phosphorylation at Threonine-80
(T80) by PLK3 (Kang et al., 2008). A strong correlation between
GSK3β inactivation and Cdc25A over-expression was observed
in some human tumors, further supporting the negative role of
GSK3βinCdc25Aproduction(Kangetal.,2008).However,under
DDR,checkpoint kinases,such as Chk1 and MK2,are in charge of
S76 phosphorylation of Cdc25A (Jin et al., 2003; Reinhardt et al.,
2007).
S82 of Cdc25A is a primary phosphorylation site in the
phospho-degron motif of Cdc25A. Several kinases have been
reportedtophosphorylateS82totriggerCdc25Aturnover(Melix-
etian et al., 2009; Honaker and Piwnica-Worms, 2010; Piao et al.,
2011). In a screen with a shRNA library, Melixetian et al. (2009)
identiﬁed NIMA (never in mitosis gene A)-related kinase 11
(NEK11)asagenethatisinvolvedintheG2/Mcheckpoint.Silenc-
ing NEK11 prevents ubiquitin-dependent proteolysis of Cdc25A,
in both unsynchronized and DNA damaged cells. NEK11 phos-
phorylates S82 of Cdc25A during DDR. Moreover, NEK11 is a
downstream effective kinase of the checkpoint pathway and is
activated via phosphorylation at Serine-273 of NEK11 by Chk1.
Thus far, there is no evidence to show whether NEK11 is capa-
ble of phosphorylating S79 of Cdc25A,although phosphorylation
of S79 is important for S82 phosphorylation of Cdc25A and
Cdc25A recognition by βTRCP. In a separate study, Honaker and
Piwnica-Worms(2010)reportedthatcaseinkinase1alpha(CK1α)
phosphorylatesCdc25AatbothS79andS82duringinterphaseand
undergenotoxicstress.Inthesamestudy,theauthorsclaimedthat
NEK11couldnotphosphorylateS82of Cdc25Ainvitro.H o wev er ,
itisunclearwhetheranyprimingkinasewasincludedintheinvitro
kinase assay. Paradoxically, Melixetian et al. (2009) found that
NEK11 can phosphorylate S82 of Cdc25A in vitro, but the phos-
phorylation was independent of S76 phosphorylation. In contrast
to the Honaker and Piwnica-Worms (2010) report, Piao et al.
(2011) observed CK1ε directly phosphorylated S82 without any
prior phosphorylation of Cdc25A, and silencing CK1ε stabilized
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cellular Cdc25A in HEK293 cells. These conﬂicting results reveal
the complexity of phosphorylation-regulated Cdc25A proteolysis
(Figure 2). They may also reﬂect the fact that Cdc25A stability is
regulated by various signaling pathways and that different genetic
background may select distinctive kinases to create a phospho-
degron motif for Cdc25A. Further experiments are needed to
clarify these discrepancies. Nevertheless,the consensus is that S76
is a priming site for generation of a phospho-degron sequence
surrounding S79 and S82.
In addition to residues surrounding S82, other serine residues
alsocontributetoDDR-inducedCdc25Adegradation.PLK3phos-
phorylates Serines-513 and -519 of Cdc25A in vitro (Myer et al.,
2011). The role of PLK3 in Cdc25A stability was studied in PLK3
knockout mice where the G1/S checkpoint was found to be defec-
tive (Myer et al., 2011). PLK3-mediated Cdc25A stabilization did
not translate into a signiﬁcant increase in tumorigenesis in vivo
(Myer et al., 2011), however, suggesting that PLK3-mediated
Cdc25A turnover may not be a major pathway to control in vivo
functions of Cdc25A.
SCFβTRCP IN CLASPIN UBIQUITINATION AND TURNOVER DURING DDR
RECOVERY
While SCFβTRCP-mediated Cdc25A degradation is critical for the
execution of the DNA damage checkpoint, SCFβTRCP-controlled
Claspin turnover is important for checkpoint recovery. Claspin
associates with the replication fork and is one of the major check-
point mediators for Chk1 activation by ATR in response to repli-
cation stress (Chini and Chen,2003; Kumagai and Dunphy,2003;
Lee et al., 2003; Lin et al., 2004). Claspin is a periodically synthe-
sizedproteinanditsexpressionpeaksatS/G2andisthendegraded
after cells transit into mitosis. In unsynchronized cells,the mitotic
degradation of Claspin depends on SCFβTRCP, which binds to
Claspin through a conserved DpSGxxpS phospho-degron motif
(Cardozo and Pagano,2004). Phosphorylation of these two serine
residuesisnecessaryforubiquitinationof Claspin.Alaninesubsti-
tutions of these serine residues abolish the association of Claspin
with SCFβTRCP and the poly-ubiquitination of Claspin (Mailand
et al., 2006; Mamely et al., 2006; Peschiaroli et al., 2006). Appar-
ently,PLK1isthekinasethatphosphorylatestheseserines,because
PLK1 is necessary for in vitro ubiquitination and siRNA depletion
of PLK1 suppresses mitotic Claspin degradation (Mailand et al.,
2006; Mamely et al.,2006).
In G2, Claspin quickly accumulates after UV damage, sug-
gesting a post-transcriptional regulatory mechanism. The level
of Claspin correlates well with activation of Chk1, represented
by phosphorylation of Serine-317 of Chk1 (Chini et al., 2006).
Chk1 phosphorylates Threonine-916 of Claspin and is important
to maintain Claspin protein stability (Bennett and Clarke, 2006;
Chini and Chen, 2006; Chini et al., 2006). Although Chk1 affects
Claspin turnover, apparently, the stability control of Clapsin is
independentofATR(ChiniandChen,2006;Chinietal.,2006;Yang
etal.,2008).Conversely,Claspinisalsoastabilizerof Chk1protein
(Yang et al., 2008). During the recovery from replication stress,
Chk1 activity is gradually diminished, concomitantly with the
reduction of Claspin level. When serine residues in the phospho-
degron of Claspin are mutated into alanine, Claspin is no longer
a substrate of the SCFβTRCP ubiquitin ligase (Mailand et al.,2006;
Mamely et al., 2006; Peschiaroli et al., 2006). Consequently, the
activation of checkpoint pathway is extended and the percentage
ofmitoticcellsisreduced(Mailandetal.,2006;Mamelyetal.,2006;
Peschiarolietal.,2006).Therefore,SCFβTRCP-dependentturnover
of Claspin is critical for cells to terminate the checkpoint pathway
once the damage is repaired (Mailand et al., 2006; Mamely et al.,
2006; Peschiaroli et al.,2006).
In summary, the SCFβTRCP ubiquitin ligase plays important
roles in multiple steps of DDR via proteolytic control of multiple
substrates which functions at different steps of DDR. Obviously,
distinct protein kinases have been shown to create a conserved
phospho-degron motif on different substrates. Nevertheless, as
the substrate receptor, βTRCP is a key player to maintain genome
integrity. Consistent with this, mutations of βTRCP1 have been
identiﬁed in human cancer (He et al., 2005). The inhibitory role
of βTRCP1 in tumorigenesis has been established (Kudo et al.,
2004; Bhatia et al., 2011), suggesting that βTRCP1 is a bona ﬁde
tumor suppressor.
CRL4Cdt2 IN DNA DAMAGE RESPONSE
DNA replication is initiated from the sequential recruitment and
assembly of regulatory proteins onto specialized chromosome
regions known as DNA replication origins. During the late M-
phaseandG1-phase,pre-replicativecomplex(pre-RC)needstobe
assembled onto origins. Origins then become “licensed” and can
further recruit DNA polymerase for replication at S-phase (Dutta
and Bell, 1997; Arias and Walter, 2007). The assembly of pre-RC
is a stepwise process that starts with binding of origin recogni-
tion complex (ORC) to an origin. ORC then recruits Cdc6 and
Cdt1, two DNA replication licensing factors which are required
for loading of MCM complex. To prevent re-replication, where
origins ﬁre more than once during a single cell cycle,it is essential
to dissemble the pre-RC complex immediately after replication is
initiated (Dutta and Bell, 1997; Arias and Walter, 2007). In Xeno-
pus and mammals, Cdt1 can be inactivated through binding to
its inhibitor,Geminin,or via ubiquitination-mediated proteolysis
(Wohlschlegel et al., 2000; Nishitani et al., 2001; Tada et al., 2001;
AriasandWalter,2005).Inhibitionof Gemininorover-expression
of Cdt1 stimulates DNA re-replication (Vaziri et al., 2003; Zhu
et al., 2004; Takeda et al., 2005). Cdt1 transgenic mice develop
thymic lymphoblastic lymphoma in the absence of p53 (Seo et al.,
2005) and over-expression of Cdt1 and Cdc6 promotes malignant
events by inducing genome instability and by abrogating antitu-
mor barriers,suggesting their oncogenic functions (Liontos et al.,
2007). Over-expression of Cdt1 and/or Cdc6 has been observed
in certain cancers (Karakaidos et al.,2004). Therefore,DNA repli-
cation licensing machine could be a good therapeutic target for
cancer cures.
CRL4Cdt2 IN DDR-INDUCED Cdt1 UBIQUITINATION AND TURNOVER
In the unperturbed cell cycle, Cdt1 is degraded after replication
is initiated at G1-/S-phase (Nishitani et al., 2001). Walter and
colleagues demonstrated that Cdt1 degradation in Xenopus egg
extract requires replication initiation (Arias and Walter, 2005).
Depletion of Cdc45 or RPA, which are essential for origin ﬁr-
ing, abolished the chromatin-associated Cdt1 ubiquitination and
degradation(AriasandWalter,2005).TwoE3ligases,SCFSkp2 and
CRL4Cdt2,are identiﬁed to mediate cell cycle-dependent degrada-
tion of Cdt1 (Higa et al., 2003, 2006; Li et al., 2003; Zhong et al.,
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2003; Hu et al., 2004; Kondo et al., 2004; Arias and Walter, 2006;
HuandXiong,2006;Jinetal.,2006;KimandKipreos,2006;Love-
joy et al., 2006; Nishitani et al., 2006; Ralph et al., 2006; Sansam
et al., 2006; Senga et al., 2006). SCFSkp2 is the main one to con-
trol Cdt1 throughout the cell cycle in a Cdk-dependent manner,
whereasCRL4Cdt2 isrequiredforCdt1degradationinS-phaseand
during DDR.
In responding to UV or γ-irradiation, Cdt1 undergoes ubiq-
uitination, and proteasome-dependent degradation, which pre-
sumably would prevent improper new origin ﬁring before the
damaged genome is repaired (Higa et al., 2003; Hu et al., 2004).
The DDR-induced ubiquitination of Cdt1 is solely dependent on
CRL4Cdt2, since the absence of Skp2 does not compromise Cdt1
degradation after UV. Deletion of Cdt2 in HeLa cells induced
DNA re-replication and G2/M checkpoint activation, partly due
to Cdt1 accumulation (Jin et al., 2006; Sansam et al., 2006).
How CRL4Cdt2 recognizes and targets Cdt1 for ubiquitination
has been intensively investigated. The degron signal recognized
by CRL4Cdt2 is localized at the N-terminus of Cdt1 since the N-
terminal fragment behaves like the full length Cdt1 in the aspect
of UV-induced degradation. Truncation mutagenesis further nar-
rows the degron region to be within the ﬁrst 10 residues, which
also encompass a PCNA-interacting motif (called PIP box). There
are evidences indicating the essential role of PCNA in Cdt1 degra-
dation (Arias and Walter, 2006; Hu and Xiong, 2006; Senga et al.,
2006). Depletion of PCNA or mutation on the PIP box abolishes
CRL4Cdt2-mediating Cdt1 ubiquitination and proteolysis in the
unperturbedS-phaseorUVdamagedcells(AriasandWalter,2006;
Hu and Xiong,2006; Senga et al.,2006). TheWalter group further
foundthataTDmotif insidethePIPboxandabasicaminoacidat
fourresiduesdownstreamofthePIPboxofCdt1areimportantfor
Cdt1 to interact with PCNA strongly and to recruit CRL4Cdt2 to
the Cdt1–PCNA complex (Havens and Walter, 2009). This obser-
vation was conﬁrmed by two individual studies (Guarino et al.,
2011; Michishita et al.,2011).
Although both UV and IR can trigger CRL4Cdt2-dependent
Cdt1 degradation, the phosphorylation event of Cdt1 is only
observed in UV damaged cells (Kondo et al., 2004). IR-induced
degradation of Cdt1 is not dependent on either ATM or ATR
checkpoint pathway, whereas UV-induced degradation is sensi-
tive to the inhibitor of ATM and ATR, caffeine (Higa et al., 2003;
Kondo et al., 2004). Although Cdt1 is phosphorylated after UV
irradiation, none of the phosphorylation events are located at the
N-terminus, where the degron motif is localized (Kondo et al.,
2004; Senga et al., 2006). However, it is still unclear why caf-
feine,as the inhibitor of ATM and ATR,only affects UV-mediated
Cdt1proteolysis.HowATMandATRregulateUV-controlledCdt1
degradation is still unclear. Further lost-of-function investiga-
tions on ATM and ATR are necessary to validate their roles in
UV-triggered Cdt1 proteolysis. Moreover, whether and how the
phosphorylations of Cdt1 at its C-terminus are linked to Cdt1
ubiquitinationandturnoverareyettobedetermined.Recentstudy
fromCook’sgroupindicatedthatp38MAPKandc-JunN-terminal
kinase (JNK) can phosphorylate Cdt1 both during unperturbed
G2phaseandunderstresscondition(Chandrasekaranetal.,2011).
These results explained why Cdt1 becomes a stable protein when
cells move into G2 and mitosis.
CRL4Cdt2 IN DDR-INDUCED p21 UBIQUITINATION AND TURNOVER
CRL4Cdt2 is a key ubiquitin ligase that mediates ubiquitination of
several important cell cycle regulators in cooperation with PCNA.
TheCdkinhibitor,p21(alsocalledWAF1orCIP1),isasubstrateof
CRL4Cdt2 inDNAreplicationlicensingcontrol.p21isaninhibitor
of Cdks whose kinase activity is required to drive Cdc6 out of the
nucleusinordertopreventDNAreplicationrelicensing(Kimetal.,
2007).p21bindstothecyclin/Cdk2complextosuppressitskinase
activity and prevents cells from entering into S-phase. In response
to different stimuli, the transcription of p21 is activated by p53,
through which cell cycle progression is arrested at the G1/S tran-
sition. In addition to functioning as a cell cycle regulator,p21 also
forms a complex with PCNA and polymerase δ. Over-expression
of p21disruptsthePCNA–Fen1interactioninvivo andpotentially
interferes with the DNA repair process (Chen et al., 1996).
Under low dose UV irradiation, p21 undergoes proteolysis,
which could potentially promote DNA repair. Two E3 ligases,
SCFSkp2 and CRL4Cdt2 are implicated in regulating p21 proteol-
ysis under DNA damage conditions (Bornstein et al., 2003; Soria
et al., 2006; Abbas et al., 2008; Kim et al., 2008; Nishitani et al.,
2008). It has been shown that degradation of p21 after low dose
UV irradiation (<40J/m2) depends on ATR and Skp2. The inter-
action between Skp2 and p21 has been detected and is further
increased after DNA damage (Bendjennat et al., 2003). Mutation
of all lysine residues impaired UV-induced p21 degradation and
cells exhibited defects in DNA repair. This implies that p21 ubiq-
uitination promotes its degradation to prompt the accumulation
of PCNAonchromatinforDNArepairprocess(Bendjennatetal.,
2003).
p21, like Cdt1, has a PIP box motif for PCNA interaction.
It was then speculated whether p21 degradation could be regu-
latedlikeCdt1,viaCRL4Cdt2-mediatedubiquitinationwithPCNA
as co-factor. Down-regulation of Cul4, DDB2, and Cdt2 in UV-
irradiated p53 null HCT116 (to eliminate the signaling from p53)
inhibited efﬁcient p21 degradation (Abbas et al., 2008). As in the
case for Cdt1, p21 ubiquitination by CRL4Cdt2 requires PCNA
bindingviathePIPbox.Theassociationof p21andCRL4Cdt2 was
detected by co-immunoprecipitation regardless of damage signal-
ing. However, CRL4Cdt2 can only ubiquitinate p21 that possesses
a phosphomimetic mutation at Serine-114, which is the target of
the GSK3β kinase stimulated by ATR (Abbas et al.,2008).
The classic E2 enzyme for CRL ubiquitin ligases is Cdc34 (Pet-
roski and Deshaies, 2005). A recent study, however, indicated that
UbcH5 may function as a priming E2 to initiate ubiquitination of
IκBα,abona ﬁde substrate of the SCFβTRCP ubiquitin ligase (Wu
et al., 2010). Given the fact that CRLs share a common RING ﬁn-
ger protein, Rbx, it is highly possible that the E2 priming step by
UbcH5 may be common to poly-ubiquitination of many, if not
all substrates of CRLs. Interestingly, the Dutta group found that
UbcH8mediatesp21ubiquitination,whereastheUBE2Gfamilyof
E2scooperatewithCRL4Cdt2 topolyubiquitylateCdt1underDDR
(Shibata et al.,2011). These data,if true,suggested that substrates
also play important roles in E2 selection of CRL ubiquitin ligases.
BecausetheseexperimentsweredonewithsinglesiRNAoligo,fur-
ther studies are needed to conﬁrm the roles of these E2 enzymes.
UbcH8lacksobviousfeaturesforpoly-ubiquitinchainformation.
Whether other E2s, such as UbcH5, can function together with
Frontiers in Oncology | Molecular and Cellular Oncology April 2012 | Volume 2 | Article 29 | 6Li and Jin CRL and DNA damage response
UbcH8 in poly-ubiquitin chain generation on p21 remains to be
determined. Moreover, like Cdc34, UBE2G E2s contain an acidic
sequencethatisrequiredforpoly-ubiquitinchainformation(Pet-
roski and Deshaies, 2005). One important question is whether
UBE2G, like Cdc34, needs assistance from another E2, such as
UbcH5, as a priming subunit to boost its poly-ubiquitination
capability.AnothercriticalquestioniswhethertheCRL4Cdt2 ubiq-
uitin ligase employs Cdc34, UbcH8, or UBE2G as E2 enzyme to
conjugate poly-ubiquitin chains on Set8/PR-Set7, another critical
substrate of CRL4Cdt2 under DDR (Abbas et al., 2010; Centore
et al., 2010; Oda et al., 2010; Jørgensen et al., 2011). Understand-
ing these questions is important to better comprehend protein
poly-ubiquitination by CRL ubiquitin ligases under DDR.
CRL4DDB2 AND CRL4CSA IN DNA REPAIR CONTROL
Nucleotide excision repair (NER) is a versatile repair mecha-
nism to remove the damaged DNA lesions from the genome,
including UV-induced cyclobutane pyrimidine dimers (CPD), 6–
4 pyrimidine–pyrimidone photoproducts, and a variety of bulky
adducts (Gillet and Schärer, 2006). It is a gap-ﬁlling process exe-
cuted by DNA polymerase and ligase following the excision of
a 24–32 DNA base oligonucleotide, where the lesion localizes.
There are two sub-types of NER, global genome repair (GGR),
andtranscription-coupledrepair(TCR),whichdifferinthemech-
anism of damage detection. GGR occurs throughout the whole
genome, whereas TCR is restricted in the active transcribing
regions. Mutations in the NER pathway are responsible for several
rare inheritable diseases, such as xeroderma pigmentosum (XP)
and Cockayne syndrome (Bootsma et al.,1998).
CRL4DDB2 IN NUCLEOTIDE EXCISION REPAIR
Xeroderma pigmentosum patients are hypersensitive to UV and
arepre-disposedtoskincancer.CellsfromXPpatientsaredefective
inrepairof UV-inducedDNAdamage(Friedberg,1995;Friedberg
et al., 1995). In XP complementation group E (XP-E), the DDB2
gene is mutated. DDB2 encodes a WD-40 repeat protein that was
originally identiﬁed as one subunit of a heterodimer with DDB1
(Dualan et al., 1995). The DDB1–DDB2 heterodimer binds to
damaged DNA and is involved in NER. The crystal structure of
DDB2–DDB1 dimer explains its high afﬁnity toward UV-induced
DNAlesionanditscentralroleinNER.ThehairpinmotifofDDB2
inserts into the minor groove of a DNA duplex and thereby ﬂips
outthepyrimidinedimertoberecognizedbythebindingpocketof
DDB2(Scrimaetal.,2008).TheDNAlesionrecognitionabilityof
DDB2isessentialforsubsequentrecruitmentof repairproteinsto
the damage site. Consistent with the clinical implication of DDB2
in human disease (XP-E),DDB2 knockout mice are susceptible to
UV-inducedskintumorigenesisanddevelopspontaneouscancers
at old age (Yoon et al., 2005).
DDB1 and DDB2 are two essential subunits of the CRL4DDB2
ubiquitin ligase where DDB2 functions as the substrate recep-
tor (Groisman et al., 2003). Thus far, the known substrates for
CRL4DDB2 arehistonesandXPC(Sugasawaetal.,2005;El-Mahdy
et al., 2006; Kapetanaki et al., 2006; Wang et al., 2006; Guerrero-
Santoro et al.,2008). CRL4DDB2 is not so active due to its associa-
tionwiththeCSN(Groismanetal.,2003).However,UVradiation
can trigger the translocation of CRL4DDB2 to chromatin. The
recruitment of CRL4DDB2 is critical for orchestrating the repair
machineryaroundthedamagesite.Chromatin-boundCRL4DDB2
is very active, because it does not associate with the CSN and its
Cul4subunitisneddylated(Groismanetal.,2003;Takedachietal.,
2010).Apparently,UVlightsendssignalstoseparatetheCSNfrom
CRL4DDB2,becausethemajorityof CRL4DDB2 bindstochromatin
after UV radiation (Groisman et al., 2003). Some DDB2 mutants
fromXP-EpatientsaredefectiveinDDB1binding(Jinetal.,2006;
Takedachi et al., 2010). These mutants fail to recruit the other
subunits of CRL4DDB2 to lesion DNA under DDR (Hwang et al.,
1998; Shiyanov et al.,1999; Jin et al.,2006; Kapetanaki et al.,2006;
Takedachietal.,2010).Asaresult,XPCandhistonesarenotubiq-
uitinated(Kapetanakietal.,2006;Takedachietal.,2010).Thismay
explain how the DNA repair machine is impaired in some XP-E
patients.
XPC is a central player in the NER pathway. XPC is necessary
for the assembly of NER complex surrounding the lesion (Sug-
asawa, 2011), whereas its DNA binding afﬁnity is less than that
of DDB2. It has been shown that the poly-ubiquitination of XPC
after UV treatment depends on the CRL4DDB2 ubiquitin ligase
and that ubiquitination can augment the DNA binding afﬁnity
of XPC instead of targeting it to the proteasome for degradation
(Batty et al.,2000;Sugasawa et al.,2005). One important question
is why poly-ubiquitination of XPC by CRL4DDB2 does not lead to
XPC proteolysis?
The poly-ubiquitination of DDB2 reduces its DNA binding
ability and leads to its degradation (Chen et al., 2001b; Nag et al.,
2001; Matsuda et al., 2005). Silencing of Cul4A was shown to sta-
bilize DDB2, to prolong the retention of DDB2 at UV-induced
lesions,and to impair the recruitment of XPC and the subsequent
removal of CPD from the genome (El-Mahdy et al., 2006). More-
over, XPC ubiquitination may accelerate DDB2 turnover (Suga-
sawa et al., 2009). Therefore, it seems likely that a UV-induced
DNA lesion is handed over from DDB2 to XPC for DNA repair
and that this process depends on the poly-ubiquitination capa-
bility of the CRL4DDB2 ubiquitin ligase (Sugasawa et al., 2009).
WhetherXPCubiquitinationtriggersDDB2degradationviaauto-
ubiquitination is still debatable. However, a recent study from
Arabidopsis suggestedthatDET1isthesubstratereceptorof CRL4
that targets DDB2 for ubiquitination and degradation (Castells
et al., 2011). Therefore, it will be interesting to see whether DET1
is responsible for UV- and Cul4A-mediated DDB2 ubiquitination
and proteolysis in human cells. Using a chemical inhibitor, Zhao
et al. (2008) demonstrated that p38MAPK is required for UV-
induced DDB2 ubiquitination and proteolysis. The same group
also found that DDB2 is phosphorylated by p38MAPK after UV
treatment.However,theactualphosphorylationsitesof DDB2are
yet to be identiﬁed. Moreover, it is still unclear whether phos-
phorylation of DDB2 under UV damage plays any critical roles
in DDB2 ubiquitination and degradation. It is also unknown
whetherp38MAPKphosphorylatesDDB2directlyorviaitsdown-
stream kinases,such as MK2. Answering these questions will help
understand the concise mechanism of NER under DDR.
In addition to XPC, histone proteins, H2A, H3, and H4, are
conjugated with a single ubiquitin by CRL4DDB2 in response to
UVirradiation.InXP-Epatient-derivedlymphoblastoidcells,UV-
induced mono-ubiquitination of H2A is impaired (Kapetanaki
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et al., 2006). On one hand, some DDB2 mutants lose their func-
tions as ubiquitin ligases, because they fail to interact with DDB1
(Jin et al., 2006; Kapetanaki et al., 2006). On the other hand, the
K244E mutant of DDB2 contains only residual binding ability to
DNA lesions (Takedachi et al., 2010). Although K244E maintains
theubiquitinationactivityofCRL4DDB2,itfailstoubiquitinatehis-
tones in nucleosome context (Takedachi et al., 2010). It has been
proposed that ubiquitination of histone proteins by CRL4DDB2
loosens up the condensed chromatin structure into a relaxation
state that is more accessible to the repair factors (Wang et al.,
2006). However, inconsistent with this hypothesis, histone ubiq-
uitination is not sufﬁcient to destabilize the nucleosome in vitro
(Takedachi et al., 2010). Therefore, one potential function of his-
toneubiquitinationistorecruitotherDNArepairfactorstolesion
DNA.OnesuchfactorcouldbeXPAwhoseassociationwithlesion
DNA is enhanced by the ubiquitination activity of CRL4DDB2
(Takedachi et al., 2010). However, XPA does have an obvious
ubiquitin-binding motif, suggesting that additional factors might
be involved in the recruitment of XPA. CRLs usually conjugate
poly-ubiquitin chains on their substrates (Petroski and Deshaies,
2005). How CRL4DDB2 is regulated to conjugate mono- versus
poly-ubiquitin chains on its substrates remains enigmatic.
CRL4CSA IN NUCLEOTIDE EXCISION REPAIR
Besides CRL4DDB2, the CRL4CSA ubiquitin ligase is also actively
involved in DNA repair (Groisman et al., 2003). In this complex,
CSA is a substrate speciﬁc factor. CSA is also a WD-40 repeat
protein and has 40% sequence homology with DDB2 from the
second to the ﬁfth WD-40 repeat. Similar to DDB2, CSA directly
binds to DDB1 and is able to assemble an E3 ligase complex
with Cul4 and Rbx1. In response to UV damage, CSA is found
associating with the stalled RNA polymerase II (RNA pol II)
(Groisman et al., 2003). Similar to CRL4DDB2, the ubiquitin lig-
ase activity of CRL4CSA is inhibited due to the binding of CSN
(Groisman et al., 2003). CSB, a DNA-dependent ATPase, is the
only substrate identiﬁed for CRL4CSA thus far. CSB preferentially
associates with elongating or stalled RNA pol II, and is poten-
tially involved in the elongation step of RNA synthesis. Both
CSA and CSB are mutated in Cockayne syndrome patients and
involved in transcription-coupled DNA repair (Li et al., 2011).
CSB ﬁbroblasts exhibit hypersensitivity to UV irradiation and a
defect in resumption of RNA synthesis after damage (Bregman
et al., 1996; Balajee et al., 1997). Moreover, poly-ubiquitination
and degradation of stalled RNA pol II in response to UV is also
impaired in CSB cells (Bregman et al., 1996). CSB is a member
of the SNF2-like family, which possesses chromatin-remodeling
activity. CSB is believed to push away the stalled RNA pol II
or to rearrange the chromatin structure so that the repair pro-
teins can get access to the lesion (Groisman et al., 2006). The key
function of CSB is to recruit histone acetyltransferase p300, NER
proteins, and the CRL4CSA ubiquitin ligase to lesion DNA (van
Gool et al., 1997; Fousteri et al., 2006); whereas, CSA is required
to recruit XAB2, the nucleosomal binding protein HMGN1, and
TFIIS in cooperation with CSB. If the lesion cannot be repaired,
CSB then initiates poly-ubiquitination and degradation of stalled
RNA pol II (Svejstrup, 2003). Three hours after damage, CSB
itself is eliminated via CRL4CSA-mediated poly-ubiquitination
and proteasome-dependent degradation (Groisman et al., 2006).
Thedegradationof CSBisnecessaryfortranscriptiontoresumeat
anormalrate,andiscoordinatedwiththedissociationof theCSN
from the CRL4CSA ubiquitin ligase (Groisman et al., 2003), indi-
cating that the ubiquitination function of CRL4CSA was inhibited
during DDR, but activated after DNA repair was accomplished.
However, how the CSN is released from the CRL4CSA ubiquitin
ligase is still unclear.
Insummary,CRL4CSA andCRL4DDB2 aretwoimportantubiq-
uitin ligases that not only function as ubiquitin ligases to ubiq-
uitinate their cognate substrates, but also play distinct roles in
recruiting critical DNA repair factors to lesion DNA upon DDR.
Multiple mutations have been identiﬁed for DDB2 and CSA from
human patients. Interestingly, most of these mutants fail to form
ubiquitin ligases with other subunits of CRL4 (Jin et al., 2006).
As a consequence, CRL4 ubiquitin ligases cannot be recruited to
damagesitestoassistDNArepair.Therefore,thesedisease-derived
mutationsallaffectactivitiesofCRL4CSA andCRL4DDB2 ubiquitin
ligases, further supporting their fundamental roles in NER.
SCFFbxo4 AND SCFFbxo31 IN CYCLIN D1 UBIQUITINATION
Cdk kinase activity is the master regulator that controls cell cycle
progression. Cdk kinase activity can be modulated via phospho-
rylation,through binding to the inhibitors,or by association with
cyclin co-factors. The level of cyclin proteins ﬂuctuates during the
cell cycle through periodic transcriptional activation or proteoly-
sis. Cyclin D1 is expressed in G1-phase and its presence activates
Cdk2forentranceintoS-phase.Topreventcellsfromenteringinto
S-phase and propagating erroneous DNA, cyclin D1 is degraded
via the ubiquitin–proteasome pathway after encountering geno-
toxic stress (Pagano et al., 1994; Diehl et al., 1997, 1998). Cyclin
D1 is over-expressed in various malignant neoplasms, suggesting
its role as an oncogene (Malumbres and Barbacid,2001). MMTV-
cyclin D1 transgenic mice develop mammary adenocarcinomas,
indicating its oncogenic role in breast cancer (Wang et al., 1994;
Hosokawaetal.,2001).Therefore,cyclinD1expressioniswellcon-
trolled during cell division. Dysregulation of cyclin D1 can lead to
genomicinstability(Pontanoetal.,2008).CyclinD1isanunstable
protein. Its ubiquitination and degradation depends on phospho-
rylation of Threonine-286 (T286), which is mediated by GSK3β
kinase (Diehl et al., 1997, 1998). Four F-box proteins, including
Fbxo4,Fbxw8,Fbxo31,and Skp2,have been reported to recognize
cyclin D1 and mediate its ubiquitination (Yu et al.,1998;Lin et al.,
2006; Okabe et al.,2006; Barbash et al.,2009; Santra et al.,2009).
When cells progress into S-phase, the T286 on cyclin D1 is
phosphorylatedbyGSK3β.PhosphorylatedT286andsurrounding
residues constitute the phospho-degron motif that is recognized
by Fbxo4, a speciﬁcity factor in the SCFFbxo4 ubiquitin ligase
(Diehl et al., 1997, 1998; Lin et al., 2006). Thus, phosphory-
lated cyclin D1 at T286 is an unstable protein that is subjected
to poly-ubiquitination by SCFFbxo4 and then degradation by the
26S proteosome (Lin et al., 2006). Importantly, the ubiquitina-
tion of cyclin D1 by SCFFbxo4 requires a small heat-shock protein,
αB crystallin (Lin et al., 2006). Over-expression of Fbxo4 and αB
crystallin can stimulate cyclin D1 ubiquitination and accelerate
its degradation, whereas knockdown of either of them can block
cyclin D1 ubiquitination and increase its protein stability (Lin
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et al., 2006). In consistent with these observations, Fbxo4 and
αB crystallin expression is reduced in subset of primary human
tumors that overexpress cyclin D1 (Lin et al., 2006). In addition
to Fbxo4, another F-box protein Fbxw8 was also identiﬁed as an
E3 ligase for cyclin D1 in HCT116 cancer cell line. Fbxw8 can
associate with either Cul1 or Cul7 to assemble an SCF or SCF-like
complex, respectively (Okabe et al., 2006). Fbxw8 also recognizes
the degron sequences surrounding phosphorylated T286. How-
ever, the phosphorylation of T286 in this case is mediated via the
MAPK pathway rather than by GSK3β in the cell context exam-
ined (Okabe et al.,2006). The access of cyclin D1 to its cognate E3
ligase is spatially regulated. Similar to Fbxo4, majority of Fbxw8
is localized in the cytoplasm during G1- and S-phase, separating
away from the nucleus localized cyclin D1. In S-phase, cyclin D1
is translocated into the cytoplasm,where it is now accessible to E3
ligase for subsequent ubiquitination and proteolysis. The phos-
phorylation of cyclin D1 by GSK3β at T286 is required for its
nuclear export (Lin et al.,2006).
In contrast to Fbxo4 and Fbxw8, Fbxo31 is speciﬁcally dedi-
cated to damage-induced degradation of cyclin D1 (Santra et al.,
2009). In response to IR or other genotoxic stress, Fbxo31 is tar-
geted by the checkpoint kinase ATM for phosphorylation, which
results in the accumulation of Fbxo31. Fbxo31 binds to the same
phospho-degron motif on cyclin D1 as Fbxo4 and Fbxw8 and
mutation of T286 abolishes the interaction between cyclin D1
and all three F-box proteins. However, blocking of the MAPK
pathway but not GSK3β prevents this damage-induced cyclin D1
degradation (Santra et al.,2009). It should be noted that the char-
acterization of these four F-box proteins were done in different
cell lines. Whether these four E3 ligases are involved in regulating
cyclinD1simultaneouslyorexclusivelyfromeachotherremainto
bedetermined.TheFbxo4knockoutmicedevelopvarioustumors
whosecyclinD1expressionisenhanced(Vaitesetal.,2011).How-
ever, a recent study in knockout mice of these ubiquitin ligases
indicated that none of these four ubiquitin ligases is required for
cyclinD1proteolysisinmouseembryonicﬁbroblasts(Kanieetal.,
2012),furthersupportingcelltype-speciﬁcregulationof cyclinD1
stability. Therefore, it is intriguing that how cells choose among
differentubiquitinligasesreactingtodifferentstimuliforcyclinD1
destruction if they all recognize the same phospho-degron motif.
Nevertheless, loss of heterozygosity of Fbxo31 has been reported
inmultiplecancers(Launonenetal.,2000;Linetal.,2001;Härkö-
nen et al.,2005; Kumar et al.,2005; Huang et al.,2010; Kogo et al.,
2011). Inactive mutations of Fbxo4 are also identiﬁed in 15% of
esophageal tumors (Barbash et al., 2008). These data support the
idea that Fbxo31 and Fbxo4 are tumor suppressors.
CONCLUSION AND PROSPECTIVE
Here we discuss how CRL ubiquitin ligases mediate protein ubiq-
uitination and turnover to enforce unidirectional signal transduc-
tion in the DDR pathway. Many of the substrate receptors of CRL
are still uncharacterized. Growing evidence suggests that more
CRL ubiquitin ligases will be found to mediate the DDR path-
wayandmoreDDR-relatedproteinswillbeidentiﬁedasubiquitin
substrates of CRLs. Thus far,the main research focus has been on
dissecting the roles of CRL1 (SCF) and CRL4 ubiquitin ligases in
DDR. Emerging evidence suggests that other cullin-related ubiq-
uitinligasesarealsoinvolvedinDDR(Ribaretal.,2007;Yasukawa
et al.,2008; Blackford et al.,2010). Further investigation is needed
to explore the functions of cullin-related ubiquitin ligases other
than CRL1 and CRL4 in DDR. Moreover, several groups have
reported knockout mice models of Cul4A and suggest an impor-
tantroleof Cul4Ainguardingthegenomestability(Kopanjaetal.,
2009; Liu et al., 2009). The homolog of Cul4A, Cul4B shares sig-
niﬁcant sequence homology with Cul4A and has some redundant
functions with Cul4A (Higa et al., 2003; Hu et al., 2004). Consid-
ering the distinct knockout phenotype of Cul4A in mice and cell
lines (Nishitani et al., 2001; Karakaidos et al., 2004), it is conceiv-
able that Cul4A and Cul4B play distinct roles in genome integrity
maintenanceviaregulatingproteinstabilityofdifferentsubstrates.
However,Cul4B also plays signiﬁcant roles in DDR (Kerzendorfer
et al., 2010). In fact, degradation of p27 and p53 seems to depend
on Cul4A solely (Banks et al., 2006; Higa et al., 2006). Therefore,
more investigation is required to unravel the relationship between
Cul4A and Cul4B and to advance our understanding of Cul4 as
genome guardian.
ACKNOWLEDGMENTS
WethankDr.LindaGuarinoforcriticalreadingofthemanuscript.
We apologize to those whose work could not be cited due to space
limitation. Jianping Jin is a Pew Scholar and is supported by a
grant (AU-1711) from the Welch Foundation.
REFERENCES
Abbas, T., Shibata, E., Park, J., Jha, S.,
Karnani, N., and Dutta, A. (2010).
CRL4Cdt2 regulates cell prolifera-
tion and histone gene expression by
targeting PR-Set7/Set8 for degrada-
tion. Mol. Cell 40, 9–21.
Abbas, T., Sivaprasad, U., Terai, K.,
Amador, V., Pagano, M., and Dutta,
A. (2008). PCNA-dependent regu-
lation of p21 ubiquitination and
degradationviatheCRL4Cdt2ubiq-
uitin ligase complex. Genes Dev. 22,
2496–2506.
Arias, E. E., and Walter, J. C. (2005).
Replication-dependent destruction
of Cdt1 limits DNA replication to a
singleroundpercellcycleinXenopus
eggextracts.GenesDev.19,114–126.
Arias, E. E., and Walter, J. C. (2006).
PCNAfunctionsasamolecularplat-
formtotriggerCdt1destructionand
preventre-replication.Nat.CellBiol.
8, 84–90.
Arias, E. E., and Walter, J. C. (2007).
Strength in numbers: preventing
rereplication via multiple mecha-
nisms in eukaryotic cells. Genes Dev.
21, 497–518.
Bai, C., Sen, P., Hofmann, K., Ma,
L., Goebl, M., Harper, J. W., and
Elledge, S. J. (1996). SKP1 connects
cell cycle regulators to the ubiquitin
proteolysis machinery through a
novel motif, the F-box. Cell 86,
263–274.
Balajee, A. S., May, A., Dianov, G. L.,
Friedberg, E. C., and Bohr, V. A.
(1997). Reduced RNA polymerase II
transcription in intact and perme-
abilized Cockayne syndrome group
B cells. Proc. Natl. Acad. Sci. U.S.A.
94, 4306–4311.
Banks,D.,Wu,M.,Higa,L.A,Gavrilova,
N., Quan, J., Ye, T., Kobayashi, R.,
Sun, H., and Zhang, H. (2006).
L2DTL/CDT2 and PCNA interact
with p53 and regulate p53 polyu-
biquitination and protein stability
through MDM2 and CUL4A/DDB1
complexes. Cell Cycle 5, 1719–1729.
Barbash, O., Egan, E., Pontano, L.
L., Kosak, J., and Diehl, J. A.
(2009). Lysine 269 is essential
for cyclin D1 ubiquitination by
the SCFFbx4/alphaB-crystallin lig-
ase and subsequent proteasome-
dependent degradation. Oncogene
28, 4317–4325.
Barbash, O., Zamﬁrova, P., Lin, D.
I., Chen, X., Yang, K., Naka-
gawa, H., Lu, F., Rustgi, A. K.,
and Diehl, J. A. (2008). Muta-
tions in Fbx4 inhibit dimerization
of the SCFFbx4 ligase and con-
tribute to cyclin D1 overexpression
in human cancer. Cancer Cell 14,
68–78.
www.frontiersin.org April 2012 | Volume 2 | Article 29 | 9Li and Jin CRL and DNA damage response
Batty, D., Rapic’-Otrin,V., Levine,A. S.,
andWood,R.D.(2000).Stablebind-
ing of human XPC complex to irra-
diatedDNAconfersstrongdiscrimi-
nationfordamagedsites.J.Mol.Biol.
300, 275–290.
Bendjennat, M., Boulaire, J., Jascur, T.,
Brickner, H., Barbier,V., Sarasin, A.,
Fotedar, A., and Fotedar, R. (2003).
UV irradiation triggers ubiquitin-
dependentdegradationof p21WAF1
to promote DNA repair. Cell 114,
599–610.
Bennett, E. J., Rush, J., Gygi, S. P.,
and Harper, J. W. (2010). Dynam-
ics of cullin-RING ubiquitin lig-
ase network revealed by systematic
quantitative proteomics. Cell 143,
951–965.
Bennett, L. N., and Clarke, P. R. (2006).
Regulation of claspin degradation
by the ubiquitin-proteosome path-
way during the cell cycle and in
response to ATR-dependent check-
point activation. FEBS Lett. 580,
4176–4181.
Bernardi, R., Liebermann, D. A.,
and Hoffman, B. (2000). Cdc25A
stability is controlled by the
ubiquitin-proteasome pathway
during cell cycle progression and
terminal differentiation. Oncogene
19, 2447–2454.
Bhatia, N., Demmer, T. A., Sharma, A.
K., Elcheva, I., and Spiegelman, V.
S. (2011). Role of β-TRCP ubiqui-
tin ligase receptor in UVB mediated
responses in skin. Arch. Biochem.
Biophys. 508, 178–184.
Blackford, A. N., Patel, R. N., Forrester,
N. A., Theil, K., Groitl, P., Stew-
art, G. S., Taylor, A. M., Morgan,
I. M., Dobner, T., Grand, R. J., and
Turnell, A. S. (2010). Adenovirus
12 E4orf6 inhibits ATR activation
bypromotingTOPBP1degradation.
Proc. Natl. Acad. Sci. U.S.A. 107,
12251–12256.
Bootsma, D., Kreamer, K. H., Cleaver,
J. E., and Hoeijmakers, J. H. (1998).
“Nucleotide excision repair syn-
dromes: xeroderma pigmento-
sum, Cockayne syndrome, and
trichothiodystrophy,” in The
Genetic Basis of Human Cancer,
eds B. Vogelsteain and K. W. Kin-
zler (New York: McGraw-Hill),
254–257.
Bornstein, G., Bloom, J., Sitry-Shevah,
D., Nakayama, K., Pagano, M., and
Hershko,A.(2003).Roleof theSCF-
Skp2 ubiquitin ligase in the degra-
dation of p21Cip1 in S phase. J. Biol.
Chem. 278, 25752–25757.
Boutros, R., Dozier, C., and Ducom-
mun,B.(2006).Thewhenandwhere
of Cdc25 phosphatases. Curr. Opin.
Cell Biol. 18, 185–191.
Bregman, D. B., Halaban, R., van Gool,
A. J., Henning, K. A., Friedberg,
E. C., and Warren, S. L. (1996).
UV-induced ubiquitination of RNA
polymerase II: a novel modiﬁca-
tiondeﬁcientinCockaynesyndrome
cells. Proc. Natl. Acad. Sci. U.S.A. 93,
11586–11590.
Busino, L., Donzelli, M., Chiesa, M.,
Guardavaccaro,D.,Ganoth,D.,Dor-
rello,N.V.,Hershko,A.,Pagano,M.,
and Draetta, G. F. (2003). Degrada-
tion of Cdc25A by β-TRCP during
S phase and in response to DNA
damage. Nature 426, 87–91.
Cangi, M. G., Piccinin, S., Pecciarini,
L., Talarico, A., Dal, Cin. E., Grassi,
S., Grizzo, A., Maestro, R., and
Doglioni, C. (2008). Constitutive
overexpression of CDC25A in pri-
mary human mammary epithelial
cells results in both defective DNA
damage response and chromosomal
breaks at fragile sites. Int. J. Cancer
123, 1466–1471.
Cardozo,T.,andPagano,M.(2004).The
SCF ubiquitin ligase: insights into a
molecular machine. Nat. Rev. Mol.
Cell Biol. 5, 739–751.
Castells, E., Molinier, J., Benvenuto,
G., Bourbousse, C., Zabulon, G.,
Zalc, A., Cazzaniga, S., Genschik,
P., Barneche, F., and Bowler, C.
(2011). The conserved factor DE-
ETIOLATED 1 cooperates with
CUL4-DDB1DDB2 to maintain
genome integrity upon UV stress.
EMBO J. 30, 1162–1172.
Centore, R. C., Havens, C. G., Man-
ning, A. L., Li, J. M., Flynn, R.
L., Tse, A., Jin, J., Dyson, N. J.,
Walter, J. C., and Zou, L. (2010).
CRL4Cdt2-mediated destruction of
the histone methyltransferase Set8
preventsprematurechromatincom-
paction in S phase. Mol. Cell 40,
22–33.
Chandrasekaran, S., Tan, T. X., Hall, J.
R., and Cook, J. G. (2011). Stress-
stimulated mitogen-activated pro-
tein kinases control the stability and
activityof theCdt1DNAreplication
licensing factor. Mol. Cell. Biol. 31,
4405–4416.
Chen, M. S., Hurov, J., White, L. S.,
Woodford-Thomas,T.,andPiwnica-
Worms, H. (2001a). Absence of
apparent phenotype in mice lacking
Cdc25C protein phosphatase. Mol.
Cell. Biol. 21, 3853–3861.
Chen, X., Zhang, Y., Douglas, L.,
and Zhou, P. (2001b). UV-damaged
DNA-binding proteins are targets
of CUL-4A-mediated ubiquitina-
tion and degradation. J. Biol. Chem.
276, 48175–48182.
Chen, U., Chen, S., Saha, P., and Dutta,
A. (1996). p21Cip1/Waf1 disrupts
the recruitment of human Fen1
by proliferating-cell nuclear anti-
gen into the DNA replication com-
plex. Proc. Natl. Acad. Sci. U.S.A. 93,
11597–11602.
Chini, C. C., and Chen, J. (2003).
Human claspin is required for repli-
cation checkpoint control. J. Biol.
Chem. 278, 30057–30062.
Chini, C. C., and Chen, J. (2006).
Repeated phosphopeptide motifs
in human claspin are phospho-
rylated by Chk1 and mediate
claspin function. J. Biol. Chem. 281,
33276–33282.
Chini, C. C., Wood, J., and Chen, J.
(2006). Chk1 is required to main-
tain claspin stability. Oncogene 25,
4165–4171.
Chiu, Y. H., Sun, Q., and Chen, Z. J.
(2007). E1-L2 activates both ubiq-
uitin and FAT10. Mol. Cell 27,
1014–1023.
Choo, Y. Y., Boh, B. K., Lou, J. J., Eng,
J., Leck, Y. C., Anders, B., Smith, P.
G.,andHagen,T.(2011).Character-
ization of the role of COP9 signalo-
some in regulating cullin E3 ubiqui-
tin ligase activity. Mol. Biol. Cell 22,
4706–4715.
Cope, G. A., and Deshaies, R. J. (2003).
COP9 signalosome: a multifunc-
tional regulator of SCF and other
cullin-based ubiquitin ligases. Cell
114, 663–671.
Cope, G. A., and Deshaies, R. J. (2006).
Targeted silencing of Jab1/Csn5 in
human cells downregulates SCF
activity through reduction of F-box
protein levels. BMC Biochem. 7, 1.
doi:10.1186/1471-2091-7-1
Cope, G. A., Suh, G. S., Aravind,
L., Schwarz, S. E., Zipursky, S. L.,
Koonin, E. V., and Deshaies, R. J.
(2002). Role of predicted metallo-
proteasemotifofJab1/Csn5incleav-
age of NEDD8 from Cul1. Science
298, 608–611.
Deshaies, R. J., Emberley, E. D., and
Saha, A. (2010). Control of cullin-
ring ubiquitin ligase activity by
NEDD8.Subcell.Biochem.54,41–56.
Diehl, J. A., Cheng, M., Roussel, M.
F., and Sherr, C. J. (1998). Glyco-
gen synthase kinase-3β regulates
cyclin D1 proteolysis and subcel-
lular localization. Genes Dev. 12,
3499–3511.
Diehl, J. A., Zindy, F., and Sherr, C.
J. (1997). Inhibition of cyclin D1
phosphorylation on threonine-286
prevents its rapid degradation via
the ubiquitin-proteasome pathway.
Genes Dev. 11, 957–972.
Donzelli, M., Busino, L., Chiesa, M.,
Ganoth, D., Hershko, A., and
Draetta, G. F. (2004). Hierar-
chical order of phosphorylation
events commits Cdc25A to βTRCP-
dependentdegradation.Cell Cycle 3,
469–471.
Donzelli, M., Squatrito, M., Ganoth,
D., Hershko, A., Pagano, M., and
Draetta, G. F. (2002). Dual mode
of degradation of Cdc25A phos-
phatase. EMBO J. 21, 4875–4884.
Dualan, R., Brody, T., Keeney, S.,
Nichols, A. F., Admon, A., and
Linn,S.(1995).Chromosomallocal-
ization and cDNA cloning of the
genes (DDB1 and DDB2) for the
p127 and p48 subunits of a human
damage-speciﬁc DNA binding pro-
tein. Genomics 29, 62–69.
Duda, D. M., Borg, L. A., Scott, D.
C., Hunt, H. W., Hammel, M., and
Schulman, B. A. (2008). Structural
insights into NEDD8 activation of
cullin-RINGligases:conformational
control of conjugation. Cell 134,
995–1006.
Duda,D. M.,Scott,D. C.,Calabrese,M.
F.,Zimmerman,E.S.,Zheng,N.,and
Schulman, B. A. (2011). Structural
regulation of cullin-RING ubiquitin
ligase complexes. Curr. Opin. Struct.
Biol. 21, 257–264.
Dutta, A., and Bell, S. P. (1997). Initia-
tion of DNA replication in eukary-
otic cells. A n n u .R e v .C e l lD e v .B i o l .
13, 293–332.
Dye, B. T., and Schulman, B. A. (2007).
Structural mechanisms underlying
posttranslational modiﬁcation by
ubiquitin-like proteins. Annu. Rev.
Biophys.Biomol.Struct.36,131–150.
El-Mahdy, M. A., Zhu, Q., Wang, Q.
E., Wani, G., Praetorius-Ibba, M.,
and Wani, A. A. (2006). Cullin 4A-
mediated proteolysis of DDB2 pro-
tein at DNA damage sites regulates
in vivo lesion recognition by XPC. J.
Biol. Chem. 281, 13404–13411.
Falck, J., Mailand, N., Syljuåsen, R. G.,
Bartek, J., and Lukas, J. (2001). The
ATM-Chk2-Cdc25A checkpoint
pathway guards against radioresis-
tant DNA synthesis. Nature 410,
842–847.
Feldman, R. M., Correll, C. C.,
Kaplan, K. B., and Deshaies, R.
J. (1997). A complex of Cdc4p,
Skp1p, and Cdc53p/cullin catalyzes
ubiquitination of the phosphory-
lated Cdk inhibitor Sic1p. Cell 91,
221–230.
Ferguson, A. M., White, L. S., Dono-
van, P. J., and Piwnica-Worms, H.
(2005).Normalcellcycleandcheck-
point responses in mice and cells
lacking Cdc25B and Cdc25C pro-
teinphosphatases.Mol.Cell.Biol.25,
2853–2860.
Fousteri, M., Vermeulen, W., van Zee-
land, A. A., and Mullenders, L.
H. (2006). Cockayne syndrome A
Frontiers in Oncology | Molecular and Cellular Oncology April 2012 | Volume 2 | Article 29 | 10Li and Jin CRL and DNA damage response
andBproteinsdifferentiallyregulate
recruitment of chromatin remodel-
ing and repair factors to stalled RNA
polymerase II in vivo. Mol. Cell 23,
471–482.
Friedberg,E.C.(1995).Outoftheshad-
owsandintothelight:theemergence
of DNA repair. Trends Biochem. Sci.
20, 381.
Friedberg, E. C., Walker, G. C., and
Siede, W. (1995). DNA Repair
and Mutagenesis (Washington, DC:
American Society of Microbiology).
Gillet, L. C., and Schärer, O. D. (2006).
Molecular mechanisms of mam-
malian global genome nucleotide
excision repair. Chem. Rev. 106,
253–276.
Goldenberg, S. J., Cascio, T. C.,
Shumway, S. D., Garbutt, K. C., Liu,
J., Xiong, Y., and Zheng, N. (2004).
Structure of the Cand1-Cul1-Roc1
complex reveals regulatory mecha-
nisms for the assembly of the multi-
subunit cullin-dependent ubiquitin
ligases. Cell 119, 517–528.
Goloudina, A., Yamaguchi, H.,
Chervyakova, D. B., Appella, E.,
Fornace, A. J. Jr., and Bulavin, D.
V. (2003). Regulation of human
Cdc25A stability by Serine 75
phosphorylation is not sufﬁcient to
activate a S phase checkpoint. Cell
Cycle 2, 473–478.
Groisman, R., Kuraoka, I., Cheval-
lier, O., Gaye, N., Magnaldo, T.,
Tanaka, K., Kisselev, A. F., Harel-
Bellan, A., and Nakatani, Y. (2006).
CSA-dependent degradation of CSB
by the ubiquitin-proteasome path-
way establishes a link between com-
plementation factors of the Cock-
ayne syndrome. Genes Dev. 20,
1429–1434.
Groisman, R., Polanowska, J., Kuraoka,
I., Sawada, J., Saijo, M., Drapkin,
R., Kisselev, A. F., Tanaka, K., and
Nakatani, Y. (2003). The ubiqui-
tin ligase activity in the DDB2 and
CSA complexes is differentially reg-
ulated by the COP9 signalosome in
response to DNA damage. Cell 113,
357–367.
Guarino, E., Shepherd, M. E., Salguero,
I., Hua, H., Deegan, R. S., and
Kearsey, S. E. (2011). Cdt1 pro-
teolysis is promoted by dual PIP
degrons and is modulated by PCNA
ubiquitination.NucleicAcidsRes.39,
5978–5990.
Guerrero-Santoro, J., Kapetanaki, M.
G., Hsieh, C. L., Gorbachinsky, I.,
Levine, A. S., and Rapic-Otrin, V.
(2008). The cullin 4B-based UV-
damaged DNA-binding protein lig-
ase binds to UV-damaged chro-
matin and ubiquitinates histone
H2A. Cancer Res. 68, 5014–5022.
Hannah, J., and Zhou, P. (2009). Reg-
ulation of DNA damage response
pathways by the cullin-RING ubiq-
uitin ligases. DNA Repair (Amst.) 8,
536–543.
Hao, B., Oehlmann, S., Sowa, M. E.,
Harper, J. W., and Pavletich, N.
P. (2007). Structure of a Fbw7-
Skp1-cyclin E complex: multisite-
phosphorylated substrate recogni-
tion by SCF ubiquitin ligases. Mol.
Cell 26, 131–143.
Härkönen, P., Kyllönen,A. P., Nordling,
S.,andVihko,P. (2005). Loss of het-
erozygosity in chromosomal region
16q24.3 associated with progres-
sion of prostate cancer. Prostate 62,
267–274.
Harper, J. W., and Elledge, S. J. (2007).
The DNA damage response: ten
years after. Mol. Cell 28, 739–745.
Havens, C. G., and Walter, J. C. (2009).
Docking of a specialized PIP Box
onto chromatin-bound PCNA cre-
ates a degron for the ubiquitin ligase
CRL4Cdt2. Mol. Cell 35, 93–104.
He, N., Li, C., Zhang, X., Sheng, T., Chi,
S., Chen, K., Wang, Q., Vertrees, R.,
Logrono,R.,and Xie,J. (2005). Reg-
ulation of lung cancer cell growth
and invasiveness by β-TRCP. Mol.
Carcinog. 42, 18–28.
Higa, L. A., Banks, D., Wu, M.,
Kobayashi, R., Sun, H., and Zhang,
H. (2006). L2DTL/CDT2 interacts
with the CUL4/DDB1 complex and
PCNA and regulates CDT1 proteol-
ysisinresponsetoDNAdamage.Cell
Cycle 5, 1675–1680.
Higa, L. A., Mihaylov, I. S., Banks, D.
P., Zheng, J., and Zhang, H. (2003).
Radiation-mediated proteolysis of
CDT1 by CUL4-ROC1 and CSN
complexes constitutes a new check-
point. Nat. Cell Biol. 5, 1008–1015.
Honaker, Y., and Piwnica-Worms,
H. (2010). Casein kinase 1 func-
tions as both penultimate and
ultimate kinase in regulating
Cdc25A destruction. Oncogene 29,
3324–3334.
Hosokawa,Y.,Papanikolaou,A.,Cardiff,
R. D., Yoshimoto, K., Bernstein, M.,
Wang, T. C., Schmidt, E. V., and
Arnold, A. (2001). In vivo analy-
sisof mammaryandnon-mammary
tumorigenesis in MMTV-cyclin D1
transgenic mice deﬁcient in p53.
Transgenic Res. 10, 471–478.
Hu, J., McCall, C. M., Ohta, T., and
Xiong, Y. (2004). Targeted ubiqui-
tination of CDT1 by the DDB1-
CUL4A-ROC1 ligase in response to
DNA damage. Nat. Cell Biol. 6,
1003–1009.
Hu, J., and Xiong, Y. (2006). An evo-
lutionarily conserved function of
proliferating cell nuclear antigen
for Cdt1 degradation by the Cul4-
Ddb1 ubiquitin ligase in response
to DNA damage. J. Biol. Chem. 281,
3753–3756.
Huang, D. T., Ayrault, O., Hunt, H. W.,
Taherbhoy,A.M.,Duda,D.M.,Scott,
D. C.,Borg,L. A.,Neale,G.,Murray,
P. J., Roussel, M. F., and Schulman,
B. A. (2009). E2-RING expansion of
the NEDD8 cascade confers speci-
ﬁcity to cullin modiﬁcation. Mol.
Cell 33, 483–495.
Huang, H. L., Zheng, W. L., Zhao, R.,
Zhang, B., and Ma, W. L. (2010).
FBXO31 is down-regulated and may
function as a tumor suppressor
in hepatocellular carcinoma. Oncol.
Rep. 24, 715–720.
Hwang, B. J., Toering, S., Francke, U.,
and Chu, G. (1998). p48 Activates
a UV-damaged-DNA binding factor
and is defective in xeroderma pig-
mentosum group E cells that lack
binding activity. Mol. Cell. Biol. 18,
4391–4399.
Hwang, J. W., Min, K. W., Tamura, T.
A., and Yoon, J. B. (2003). TIP120A
associates with unneddylated cullin
1andregulatesitsneddylation.FEBS
Lett. 541, 102–108.
Jin, J., Ang, X. L., Ye, X., Living-
stone, M., and Harper, J. W. (2008).
Differential roles for checkpoint
kinases in DNA damage-dependent
degradation of the Cdc25A pro-
tein phosphatase. J. Biol. Chem. 283,
19322–19328.
Jin, J., Arias, E. E., Chen, J., Harper, J.
W., and Walter, J. C. (2006). A fam-
ilyof diverseCul4-Ddb1-interacting
proteins includes Cdt2, which is
required for S phase destruction of
thereplicationfactorCdt1.Mol. Cell
23, 709–721.
Jin, J., Li, X., Gygi, S. P., and Harper, J.
W. (2007). Dual E1 activation sys-
tems for ubiquitin differentially reg-
ulate E2 enzyme charging. Nature
447, 1135–1138.
Jin, J., Shirogane, T., Xu, L., Nalepa, G.,
Qin, J., Elledge, S. J., and Harper, J.
W.(2003).SCFβTRCP linksChk1sig-
nalingtodegradationof theCdc25A
protein phosphatase. Genes Dev. 17,
3062–3074.
Jones, J., Wu, K., Yang, Y., Guerrero,
C., Nillegoda, N., Pan, Z. Q., and
Huang, L. (2008). A targeted pro-
teomic analysis of the ubiquitin-
like modiﬁer NEDD8 and associ-
ated proteins. J. Proteome Res. 7,
1274–1287.
Jørgensen, S., Eskildsen, M., Fugger,
K., Hansen, L., Larsen, M. S.,
Kousholt, A. N., Syljuåsen, R. G.,
Trelle, M. B., Jensen, O. N., Helin,
K., and Sørensen, C. S. (2011).
SET8isdegradedviaPCNA-coupled
CRL4CDT2 ubiquitination in S
phase and after UV irradiation. J.
Cell Biol. 192, 43–54.
Jura, N., Scotto-Lavino, E., Sobczyk,
A., and Bar-Sagi, D. (2006). Dif-
ferential modiﬁcation of Ras pro-
teinsbyubiquitination.Mol. Cell 21,
679–687.
Kamura, T., Koepp, D. M., Conrad,
M. N., Moreland, R. J., Iliopou-
los, O., Lane, W. S., Kaelin, W. G.
Jr., Elledge, S. J., Conaway, R. C.,
Harper, J. W., and Conaway, J. W.
(1999). Rbx1, a component of the
VHLtumorsuppressorcomplexand
SCF ubiquitin ligase. Science 284,
657–661.
Kamura, T., Maenaka, K., Kotoshiba,
S., Matsumoto, M., Kohda, D.,
Conaway, R. C., Conaway, J. W.,
and Nakayama, K. I. (2004). VHL-
box and SOCS-box domains deter-
mine binding speciﬁcity for Cul2-
Rbx1 and Cul5-Rbx2 modules of
ubiquitin ligases. Genes Dev. 18,
3055–3065.
Kang, T., Wei, Y., Honaker, Y., Yam-
aguchi, H., Appella, E., Hung,
M. C., and Piwnica-Worms, H.
(2008). GSK-3 β targets Cdc25A for
ubiquitin-mediated proteolysis, and
GSK-3βinactivationcorrelateswith
Cdc25A overproduction in human
cancers. Cancer Cell 13, 36–47.
Kanie, T., Onoyama, I., Matsumoto, A.,
Yamada,M.,Nakatsumi,H.,Tateishi,
Y., Yamamura, S., Tsunematsu, R.,
Matsumoto, M., and Nakayama, K.
I. (2012). Genetic reevaluation of
the role of F-box proteins in cyclin
D1 degradation. Mol. Cell. Biol. 32,
590–605.
Kapetanaki, M. G., Guerrero-Santoro,
J., Bisi, D. C., Hsieh, C. L., Rapic-
Otrin, V., and Levine, A. S. (2006).
The DDB1-CUL4ADDB2 ubiquitin
ligase is deﬁcient in xeroderma pig-
mentosum group E and targets his-
tone H2A at UV-damaged DNA
sites.Proc.Natl.Acad.Sci.U.S.A.103,
2588–2593.
Karakaidos, P., Taraviras, S., Vassil-
iou, L. V., Zacharatos, P., Kastri-
nakis, N. G., Kougiou, D., Koulouk-
oussa, M., Nishitani, H., Papavassil-
iou, A. G., Lygerou, Z., and Gor-
goulis, V. G. (2004). Overexpres-
sion of the replication licensing reg-
ulators hCdt1 and hCdc6 charac-
terizes a subset of non-small-cell
lung carcinomas: synergistic effect
with mutant p53 on tumor growth
and chromosomal instability – evi-
dence of E2F-1 transcriptional con-
trol over hCdt1. Am. J. Pathol. 165,
1351–1365.
Karlsson-Rosenthal, C., and Millar, J.
B. (2006). Cdc25: mechanisms of
www.frontiersin.org April 2012 | Volume 2 | Article 29 | 11Li and Jin CRL and DNA damage response
checkpoint inhibition and recovery.
Trends Cell Biol. 16, 285–292.
Kasahara, K., Goto, H., Enomoto,
M., Tomono, Y., Kiyono, T., and
Inagaki, M. (2010). 14-3-3gamma
mediates Cdc25A proteolysis to
block premature mitotic entry
after DNA damage. EMBO J. 29,
2802–2812.
Kawakami, T., Chiba, T., Suzuki, T.,
Iwai, K., Yamanaka, K., Minato, N.,
Suzuki,H.,Shimbara,N.,Hidaka,Y.,
Osaka, F., Omata, M., and Tanaka,
K. (2001). NEDD8 recruits E2-
ubiquitin to SCF E3 ligase. EMBO
J. 20, 4003–4012.
Kerzendorfer, C., Whibley, A., Carpen-
ter, G., Outwin, E., Chiang, S.-C.,
Turner,G.,Schwartz,C.,El-Khamisy,
S., Raymond, F. L., and O’Driscoll,
M. (2010). Mutations in cullin 4B
result in a human syndrome asso-
ciatedwithincreasedcamptothecin-
induced topoisomerase I-dependent
DNA breaks. Hum. Mol. Genet. 19,
1324–1334.
Kim, J., Feng, H., and Kipreos, E.
T. (2007). C. elegans CUL-4p r e -
ventsrereplicationbypromotingthe
nuclear export of CDC-6 via a CKI-
1-dependent pathway. Curr. Biol. 17,
966–972.
Kim, Y., and Kipreos, E. T. (2006).
The Caenorhabditis elegans replica-
tion licensing factor CDT-1 is tar-
geted for degradation by the CUL-
4/DDB-1 complex. Mol. Cell. Biol.
27, 1394–1406.
Kim, Y., Starostina, N. G., and Kipreos,
E. T. (2008). The CRL4Cdt2 ubiq-
uitin ligase targets the degrada-
tion of p21Cip1 to control repli-
cation licensing. Genes Dev. 22,
2507–2519.
Kogo, R., Mimori, K., Tanaka, F.,
Komune, S., and Mori, M. (2011).
FBXO31 determines poor prog-
nosis in esophageal squamous
cell carcinoma. Int. J. Oncol. 39,
155–159.
Kondo, T., Kobayashi, M., Tanaka, J.,
Yokoyama, A., Suzuki, S., Kato, N.,
Onozawa, M., Chiba, K., Hashino,
S., Imamura, M., Minami, Y.,
Minamino, N., and Asaka, M.
(2004). Rapid degradation of Cdt1
upon UV-induced DNA damage is
mediated by SCFSkp2 complex. J.
Biol. Chem. 279, 27315–27319.
Kopanja, D., Stoyanova, T., Okur, M.
N., Huang, E., Bagchi, S., and Ray-
chaudhuri, P. (2009). Proliferation
defects and genome instability in
cells lacking Cul4A. Oncogene 28,
2456–2465.
Kristjánsdóttir, K., and Rudolph, J.
(2004). Cdc25 phosphatases and
cancer. Chem. Biol. 11, 1043–1051.
Kudo, Y., Guardavaccaro, D., Santa-
maria, P. G., Koyama-Nasu, R.,
Latres, E., Bronson, R.,Yamasaki, L.,
and Pagano, M. (2004). Role of F-
box protein βTRCP1 in mammary
gland development and tumorigen-
esis. Mol. Cell. Biol. 24, 8184–8194.
Kumagai,A.,andDunphy,W.G.(2003).
Repeated phosphopeptide motifs in
claspin mediate the regulated bind-
ing of Chk1. Nat. Cell Biol. 5,
161–165.
Kumar, R., Neilsen, P. M., Crawford, J.,
McKirdy, R., Lee, J., Powell, J. A.,
Saif, Z., Martin, J. M., Lombaerts,
M., Cornelisse, C. J., Cleton-Jansen,
A. M., and Callen, D. F. (2005).
FBXO31isthechromosome16q24.3
senescence gene, a candidate breast
tumor suppressor,and a component
of an SCF complex. Cancer Res. 65,
11304–11313.
Kurz, T., Chou, Y. C., Willems, A. R.,
Meyer-Schaller, N., Hecht, M. L.,
Tyers, M., Peter, M., and Sicheri, F.
(2008).Dcn1functionsasascaffold-
typeE3ligaseforcullinneddylation.
Mol. Cell 29, 23–35.
Kurz,T.,Ozlü,N.,Rudolf,F.,O’Rourke,
S. M., Luke, B., Hofmann, K.,
Hyman, A. A., Bowerman, B., and
Peter, M. (2005). The conserved
protein DCN-1/Dcn1p is required
for cullin neddylation in C. ele-
gans and S. cerevisiae. Nature 435,
1257–1261.
Launonen, V., Mannermaa, A., Sten-
bäck, F., Kosma, V. M., Puistola,
U., Huusko, P., Anttila, M., Bloigu,
R., Saarikoski, S., Kauppila, A., and
Winqvist, R. (2000). Loss of het-
erozygosity at chromosomes 3, 6, 8,
11,16,and17inovariancancer:cor-
relation to clinicopathological vari-
ables. Cancer Genet. Cytogenet. 122,
49–54.
Lee,J.,Kumagai,A.,and Dunphy,W. G.
(2003). Claspin, a Chk1-regulatory
protein, monitors DNA replication
onchromatinindependentlyofRPA,
ATR, and Rad17. Mol. Cell 11,
329–340.
Lee, P. C., Sowa, M. E., Gygi, S. P., and
Harper, J. W. (2011). Alternative
ubiquitin activation/conjugation
cascades interact with N-end rule
ubiquitin ligases to control degrada-
tion of RGS proteins. Mol. Cell 43,
392–405.
Li, J., Bhat, A., and Xiao, W. (2011).
Regulation of nucleotide excision
repair through ubiquitination. Acta
Biochim. Biophys. Sin. 43, 919–929.
Li, X., Zhao, Q., Liao, R., Sun, P.,
and Wu, X. (2003). The SCFSkp2
ubiquitin ligase complex interacts
with the human replication licens-
ing factor Cdt1 and regulates Cdt1
degradation. J. Biol. Chem. 278,
30854–30858.
Lin, D. I., Barbash, O., Kumar, K. G.,
Weber, J. D., Harper, J. W., Klein-
Szanto, A. J., Rustgi, A., Fuchs,
S. Y., and Diehl, J. A. (2006).
Phosphorylation-dependent ubiq-
uitination of cyclin D1 by the
SCFFBX4-alphaB crystallin com-
plex. Mol. Cell 24, 355–366.
Lin, S. Y., Li, K., Stewart, G. S., and
Elledge, S. J. (2004). Human claspin
workswithBRCA1tobothpositively
andnegativelyregulatecellprolifera-
tion.Proc.Natl.Acad.Sci.U.S.A.101,
6484–6489.
Lin, Y. W., Lee, I. N., Chen, C. H.,
Huang, G. T., Lee, H. S., Lee, P. H.,
Lu, F. J., and Sheu, J. C. (2001).
Deletion mapping of chromosome
16q24 in hepatocellular carcinoma
in Taiwan and mutational analy-
sis of the 17-β-HSD gene localized
to the region. Int. J. Cancer 93,
74–79.
Liontos, M., Koutsami, M., Sideri-
dou, M., Evangelou, K., Kletsas,
D., Levy, B., Kotsinas, A., Nahum,
O., Zoumpourlis, V., Kouloukoussa,
M., Lygerou, Z., Taraviras, S.,
Kittas, C., Bartkova, J., Papavas-
siliou, A. G., Bartek, J., Hala-
zonetis, T. D., and Gorgoulis, V.
G. (2007). Deregulated overexpres-
sion of hCdt1 and hCdc6 promotes
malignant behavior. Cancer Res. 67,
10899–10909.
Liu, J., Furukawa, M., Matsumoto,
T., and Xiong, Y. (2002). NEDD8
modiﬁcation of CUL1 dissociates
p120CAND1,an inhibitor of CUL1-
SKP1 binding and SCF ligases. Mol.
Cell 10, 1511–1518.
Liu, L., Lee, S., Zhang, J., Peters, S. B.,
Hannah,J.,Zhang,Y.,Yin,Y.,Koff,A.,
Ma,L.,and Zhou,P. (2009). CUL4A
abrogation augments DNA dam-
age response and protection against
skin carcinogenesis. Mol. Cell 34,
4514–4560.
Lovejoy,C.A.,Lock,K.,Yenamandra,A.,
and Cortez, D. (2006). DDB1 main-
tains genome integrity through reg-
ulation of Cdt1. Mol. Cell. Biol. 26,
7977–7990.
Lyapina, S. A., Correll, C. C., Kipreos,
E. T., and Deshaies, R. J. (1998).
HumanCUL1formsanevolutionar-
ily conserved ubiquitin ligase com-
plex (SCF) with SKP1 and an F-box
protein. Proc. Natl. Acad. Sci. U.S.A.
95, 7451–7456.
Lykke-Andersen, K., Schaefer, L.,
Menon, S., Deng, X. W., Miller, J.
B., and Wei, N. (2003). Disruption
of the COP9 signalosome Csn2
subunit in mice causes deﬁcient cell
proliferation, accumulation of p53
and cyclin E, and early embryonic
death.Mol.Cell.Biol.23,6790–6797.
Ma, T., Shi, T., Huang, J.,Wu, L., Hu, F.,
He, P., Deng, W., Gao, P., Zhang, Y.,
Song,Q.,Ma,D.,andQiu,X.(2008).
DCUN1D3,anovelUVC-responsive
genethatisinvolvedincellcyclepro-
gression and cell growth. Cancer Sci.
99, 2128–2135.
Mailand, N., Bekker-Jensen, S., Bartek,
J., and Lukas, J. (2006). Destruc-
tionofclaspinbySCFβTRCP restrains
Chk1 activation and facilitates
recovery from genotoxic stress. Mol.
Cell 23, 307–318.
Mailand, N., Falck, J., Lukas, C.,
Syljuâsen,R.G.,Welcker,M.,Bartek,
J., and Lukas, J. (2000). Rapid
destruction of human Cdc25A in
response to DNA damage. Science
288, 1425–1429.
Mailand, N., Podtelejnikov, A. V.,
Groth, A., Mann, M., Bartek, J.,
and Lukas, J. (2002). Regulation of
G(2)/M events by Cdc25A through
phosphorylation-dependent modu-
lation of its stability. EMBO J. 21,
5911–5920.
Malumbres, M., and Barbacid, M.
(2001). To cycle or not to cycle: a
critical decision in cancer. Nat. Rev.
Cancer 1, 222–231.
Mamely, I., van Vugt, M. A., Smits, V.
A., Semple, J. I., Lemmens, B., Per-
rakis,A.,Medema,R. H.,and Freire,
R. (2006). Polo-like kinase-1 con-
trols proteasome-dependent degra-
dation of claspin during check-
point recovery. Curr. Biol. 16,
1950–1955.
Matsuda, N., Azuma, K., Saijo, M.,
Iemura, S., Hioki, Y., Natsume, T.,
Chiba, T., Tanaka, K., and Tanaka,
K. (2005). DDB2, the xeroderma
pigmentosum group E gene prod-
uct, is directly ubiquitylated by
cullin 4A-based ubiquitin ligase
complex. DNA Repair (Amst.) 4,
537–545.
Melixetian, M., Klein, D. K., Sørensen,
C. S., and Helin, K. (2009). NEK11
regulates CDC25A degradation and
the IR-induced G2/M checkpoint.
Nat. Cell Biol. 11, 1247–1253.
Messick, T. E., and Greenberg, R. A.
(2009). The ubiquitin landscape at
DNA double-strand breaks. J. Cell
Biol. 187, 319–326.
Meyer-Schaller,N.,Chou,Y.C.,Sumara,
I., Martin, D. D., Kurz, T., Katheder,
N.,Hofmann,K.,Berthiaume,L. G.,
Sicheri,F.,and Peter,M. (2009). The
human Dcn1-like protein DCNL3
promotesCul3neddylationatmem-
branes. Proc. Natl. Acad. Sci. U.S.A.
106, 12365–12370.
Michishita, M., Morimoto, A., Ishii, T.,
Komori, H., Shiomi, Y., Higuchi, Y.,
Frontiers in Oncology | Molecular and Cellular Oncology April 2012 | Volume 2 | Article 29 | 12Li and Jin CRL and DNA damage response
and Nishitani, H. (2011). Positively
charged residues located down-
stream of PIP box, together with
TD amino acids within PIP box, are
important for CRL4Cdt2-mediated
proteolysis. Genes Cells 16, 12–22.
Min, K. W., Hwang, J. W., Lee, J. S.,
Park, Y., Tamura, T. A., and Yoon,
J. B. (2003). TIP120A associates
with cullins and modulates ubiqui-
tin ligase activity. J. Biol. Chem. 278,
15905–15910.
Molinari,M.,Mercurio,C.,Dominguez,
J., Goubin, F., and Draetta, G. F.
(2000). Human Cdc25A inactiva-
tion in response to S phase inhi-
bition and its role in preventing
premature mitosis. EMBO Rep. 1,
71–79.
Myer, D. L., Robbins, S. B., Yin, M.,
Boivin, G. P., Liu, Y., Greis, K. D.,
Bahassi, E. M., and Stambrook, P. J.
(2011). Absence of polo-like kinase
3 in mice stabilizes Cdc25A after
DNA damage but is not sufﬁcient
to produce tumors. Mutat. Res. 714,
1–10.
Nag, A., Bondar, T., Shiv, S., and Ray-
chaudhuri,P.(2001).Thexeroderma
pigmentosum group E gene product
DDB2isaspeciﬁctargetof cullin4A
in mammalian cells. Mol. Cell. Biol.
21, 6738–6747.
Negrini, S., Gorgoulis, V. G., and Hala-
zonetis,T.D.(2010).Genomicinsta-
bility – an evolving hallmark of can-
cer. Nat. Rev. Mol. Cell Biol. 11,
220–228.
Nishitani, H., Shiomi, Y., Iida, H.,
Michishita, M., Takami, T.,
and Tsurimoto, T. (2008). Cdk
inhibitor p21 is degraded by a
proliferating cell nuclear antigen-
coupled Cul4-DDB1Cdt2 pathway
during S phase and after UV
irradiation. J. Biol. Chem. 283,
29045–29052.
Nishitani, H., Sugimoto, N., Roukos,
V., Nakanishi, Y., Saijo, M., Obuse,
C., Tsurimoto, T., Nakayama, K. I.,
Nakayama, K., Fujita, M., Lygerou,
Z., and Nishimoto, T. (2006).
Two E3 ubiquitin ligases, SCF-
Skp2andDDB1-Cul4,targethuman
Cdt1 for proteolysis. EMBO J. 25,
1126–1136.
Nishitani, H., Taraviras, S., Lygerou,
Z., and Nishimoto, T. (2001). The
human licensing factor for DNA
replication Cdt1 accumulates in G1
and is destabilized after initiation
of S-phase. J. Biol. Chem. 276,
44905–44911.
Oda,H.,Hübner,M.R.,Beck,D.B.,Ver-
meulen, M., Hurwitz, J., Spector, D.
L., and Reinberg, D. (2010). Regula-
tion of the histone H4 monomethy-
lasePR-Set7byCRL4Cdt2-mediated
PCNA-dependent degradation dur-
ing DNA damage. Mol. Cell 40,
364–376.
Ohta, T., Michel, J. J., Schottelius, A.
J., and Xiong, Y. (1999). ROC1, a
homolog of APC11, represents a
family of cullin partners with an
associated ubiquitin ligase activity.
Mol. Cell 3, 535–541.
Okabe, H., Lee, S. H., Phuchareon,
J., Albertson, D. G., McCormick,
F., and Tetsu, O. (2006). A crit-
ical role for Fbxw8 and MAPK
in cyclin D1 degradation and can-
cer cell proliferation. PLoS ONE
1, e128. doi:10.1371/journal.pone.
0000128
Oshikawa, K., Matsumoto, M., Yada,
M.,Kamura,T.,Hatakeyama,S.,and
Nakayama, K. I. (2003). Preferential
interaction of TIP120A with Cul1
that is not modiﬁed by NEDD8
and not associated with Skp1.
Biochem. Biophys. Res. Commun.
303, 1209–1216.
Pagano, M., Theodoras, A. M., Tam,
S. W., and Draetta, G. F. (1994).
Cyclin D1-mediated inhibition of
repair and replicative DNA synthe-
sis in human ﬁbroblasts. Genes Dev.
8, 1627–1639.
Panattoni, M., Sanvito, F., Basso, V.,
Doglioni, C., Casorati, G., Mon-
tini, E., Bender, J. R., Mondino,
A., and Pardi, R. (2008). Targeted
inactivation of the COP9 signalo-
some impairs multiple stages of T
cell development. J. Exp. Med. 205,
465–477.
Pelzer, C., Kassner, I., Matentzoglu,
K., Singh, R. K., Wollscheid, H.
P., Scheffner, M., Schmidtke, G.,
and Groettrup, M. (2007). UBE1L2,
a novel E1 enzyme speciﬁc for
ubiquitin. J. Biol. Chem. 282,
23010–23014.
Peschiaroli, A., Dorrello, N. V., Guar-
davaccaro, D., Venere, M., Hala-
zonetis, T., Sherman, N. E., and
Pagano, M. (2006). SCFβTRCP-
mediateddegradationofclaspinreg-
ulates recovery from the DNA repli-
cation checkpoint response. Mol.
Cell 23, 319–329.
Petroski, M. D., and Deshaies, R.
J. (2005). Function and regula-
tion of cullin-RING ubiquitin lig-
ases. Nat. Rev. Mol. Cell Biol. 6,
9–20.
Piao, S., Lee, S. J., Xu, Y., Gwak, J., Oh,
S., Park, B. J., and Ha, N. C. (2011).
CK1ε targets Cdc25A for ubiquitin-
mediated proteolysis under nor-
mal conditions and in response to
checkpoint activation. Cell Cycle 10,
531–537.
Pickart,C.M.(2004).Backtothefuture
with ubiquitin. Cell 116, 181–190.
Pickart, C. M., and Eddins, M. J.
(2004). Ubiquitin: structures, func-
tions, mechanisms. Biochim. Bio-
phys. Acta 1695, 55–72.
Pontano, L. L., Aggarwal, P., Barbash,
O., Brown, E. J., Bassing, C. H.,
and Diehl, J. A. (2008). Genotoxic
stress-induced cyclin D1 phospho-
rylation and proteolysis are required
for genomic stability. Mol. Cell. Biol.
28, 7245–7258.
Ralph, E., Boye, E., and Kearsey, S.
E. (2006). DNA damage induces
Cdt1 proteolysis in ﬁssion yeast
through a pathway dependent on
Cdt2 and Ddb1. EMBO Rep. 7,
1134–1139.
Ray, D., and Kiyokawa, H. (2007).
CDC25A levels determine the bal-
anceof proliferationandcheckpoint
response. Cell Cycle 6, 3039–3042.
Ray, D., and Kiyokawa, H. (2008).
CDC25A phosphatase: a rate-
limiting oncogene that determines
genomic stability. Cancer Res. 68,
1251–1253.
Ray, D., Terao, Y., Nimbalkar, D.,
Hirai, H., Osmundson, E. C., Zou,
X., Franks, R., Christov, K., and
Kiyokawa, H. (2007a). Hemizygous
disruption of Cdc25A inhibits cel-
lular transformation and mammary
tumorigenesis in mice. Cancer Res.
67, 6605–6611.
Ray, D., Terao, Y., Fuhrken, P. G.,
Ma, Z. Q., DeMayo, F. J., Chris-
tov, K., Heerema, N. A., Franks,
R., Tsai, S. Y., Papoutsakis, E.
T., and Kiyokawa, H. (2007b).
Deregulated CDC25A expression
promotes mammary tumorigenesis
withgenomicinstability.CancerRes.
67, 984–991.
Reinhardt, H. C., Aslanian, A. S., Lees,
J. A., and Yaffe, M. B. (2007). p53-
deﬁcient cells rely on ATM- and
ATR-mediated checkpoint signaling
through the p38MAPK/MK2 path-
way for survival after DNA damage.
Cancer Cell 11, 175–189.
Ribar, B., Prakash, L., and Prakash, S.
(2007).ELA1andCUL3arerequired
along with ELC1 for RNA poly-
merase II polyubiquitination and
degradation in DNA-damaged yeast
cells. Mol. Cell. Biol. 27, 3211–3216.
Rudolph, J. (2007). Cdc25 phos-
phatases: structure, speciﬁcity,
and mechanism. Biochemistry 46,
3595–3604.
Saha,A.,andDeshaies,R.J.(2008).Mul-
timodal activation of the ubiquitin
ligase SCF by NEDD8 conjugation.
Mol. Cell 32, 21–31.
Sansam, C. L., Shepard, J. L., Lai, K.,
Ianari, A., Danielian, P. S., Amster-
dam, A., Hopkins, N., and Lees, J.
A. (2006). DTL/CDT2 is essential
for both CDT1 regulation and the
early G2/M checkpoint. Genes Dev.
20, 3117–3129.
Santra,M.K.,Wajapeyee,N.,andGreen,
M.R.(2009).F-boxproteinFBXO31
mediates cyclin D1 degradation to
induce G1 arrest after DNA damage.
Nature 459, 722–725.
Sarikas, A., Hartmann, T., and Pan, Z.
Q. (2011). The cullin protein family.
Genome Biol. 12, 220.
Scrima, A., Konícková, R., Czyzewski,
B. K., Kawasaki, Y., Jeffrey, P. D.,
Groisman, R., Nakatani, Y., Iwai,
S., Pavletich, N. P., and Thomä,
N. H. (2008). Structural basis of
UV DNA-damage recognition by
the DDB1-DDB2 complex. Cell 135,
1213–1223.
Senga, T., Sivaprasad, U., Zhu,W., Park,
J. H., Arias, E. E., Walter, J. C.,
and Dutta, A. (2006). PCNA is a
cofactor for Cdt1 degradation by
CUL4/DDB1-mediated N-terminal
ubiquitination. J. Biol. Chem. 281,
6246–6252.
Seo, J., Chung, Y. S., Sharma, G. G.,
Moon, E., Burack, W. R., Pandita, T.
K., and Choi, K. (2005). Cdt1 trans-
genic mice develop lymphoblastic
lymphoma in the absence of p53.
Oncogene 24, 8176–8186.
Seol, J. H., Feldman, R. M., Zachariae,
W., Shevchenko, A., Correll, C.
C., Lyapina, S., Chi, Y., Galova,
M., Claypool, J., Sandmeyer, S.,
Nasmyth, K., Shevchenko, A., and
Deshaies, R. J. (1999). Cdc53/cullin
and the essential Hrt1 RING-H2
subunit of SCF deﬁne a ubiqui-
tin ligase module that activates the
E2 enzyme Cdc34. Genes Dev. 13,
1614–1626.
Serino,G.,and Deng,X.W. (2003). The
COP9 signalosome: regulating plant
development through the control of
proteolysis.Annu.Rev.PlantBiol.54,
165–182.
Shibata, E., Abbas, T., Huang, X.,
Wohlschlegel, J. A., and Dutta,
A. (2011). Selective ubiquitination
of p21 and Cdt1 by UBCH8
and UBE2G ubiquitin-conjugating
enzymes via the CRL4Cdt2 ubiqui-
tinligasecomplex.Mol.Cell.Biol.31,
3136–3145.
Shimuta, K., Nakajo, N., Uto, K.,
Hayano, Y., Okazaki, K., and Sagata,
N. (2002). Chk1 is activated tran-
siently and targets Cdc25A for
degradation at the Xenopus mid-
blastula transition. EMBO J. 21,
3694–3703.
Shiyanov, P., Hayes, S. A., Donepudi,
M., Nichols,A. F., Linn, S., Slagle, B.
L.,andRaychaudhuri,P.(1999).The
naturallyoccurringmutantsof DDB
are impaired in stimulating nuclear
www.frontiersin.org April 2012 | Volume 2 | Article 29 | 13Li and Jin CRL and DNA damage response
import of the p125 subunit and
E2F1-activated transcription. Mol.
Cell. Biol. 19, 4935–4943.
Silverman,J. S.,Skaar,J. R.,and Pagano,
M. (2012). SCF ubiquitin ligases
in the maintenance of genome
stability. Trends Biochem. Sci. 37,
66–73.
Skowyra, D., Craig, K. L., Tyers,
M., Elledge, S. J., and Harper,
J. W. (1997). F-box proteins are
receptors that recruit phospho-
rylated substrates to the SCF
ubiquitin-ligase complex. Cell 91,
209–219.
Skowyra, D., Koepp, D. M., Kamura,
T., Conrad, M. N., Conaway, R.
C., Conaway, J. W., Elledge, S. J.,
and Harper, J. W. (1999). Recon-
stitution of G1 cyclin ubiquiti-
nation with complexes containing
SCFGrr1 and Rbx1. Science 284,
662–665.
Sørensen, C. S., Syljuåsen, R. G., Falck,
J., Schroeder, T., Rönnstrand, L.,
Khanna,K.K.,Zhou,B.B.,Bartek,J.,
and Lukas, J. (2003). Chk1 regulates
the S phase checkpoint by coupling
the physiological turnover and ion-
izing radiation-induced accelerated
proteolysis of Cdc25A. Cancer Cell
3, 247–258.
Soria, G., Podhajcer, O., Prives,
C., and Gottifredi, V. (2006).
p21Cip1/WAF1 downregulation
is required for efﬁcient PCNA
ubiquitination after UV irradiation.
Oncogene 25, 2829–2838.
Sugasawa, K. (2011). Multiple DNA
damage recognition factors involved
in mammalian nucleotide exci-
sion repair. Biochemistry Mosc. 76,
16–23.
Sugasawa, K., Akagi, J., Nishi, R., Iwai,
S., and Hanaoka, F. (2009). Two-
step recognition of DNA damage
for mammalian nucleotide exci-
sion repair: directional binding
of the XPC complex and DNA
strand scanning. Mol. Cell 36,
642–653.
Sugasawa, K., Okuda, Y., Saijo, M.,
Nishi, R., Matsuda, N., Chu, G.,
Mori, T., Iwai, S., Tanaka, K.,
Tanaka, K., and Hanaoka, F. (2005).
UV-induced ubiquitination of XPC
protein mediated by UV-DDB-
ubiquitin ligase complex. Cell 121,
387–400.
Svejstrup, J. Q. (2003). Rescue of
arrested RNA polymerase II com-
plexes. J. Cell Sci. 116, 447–451.
Tada, S., Li, A., Maiorano, D., Méchali,
M., and Blow, J. J. (2001). Repres-
sionoforiginassemblyinmetaphase
depends on inhibition of RLF-
B/Cdt1 by geminin. Nat. Cell Biol.
3, 107–113.
Takeda, D. Y., Parvin, J. D., and Dutta,
A. (2005). Degradation of Cdt1 dur-
ing S phase is Skp2-independent
and is required for efﬁcient progres-
sion of mammalian cells through
S phase. J. Biol. Chem. 280,
23416–23423.
Takedachi, A., Saijo, M., and Tanaka,
K.(2010).DDB2complex-mediated
ubiquitylationaroundDNAdamage
is oppositely regulated by XPC and
Ku and contributes to the recruit-
ment of XPA. Mol. Cell. Biol. 30,
2708–2723.
Tan, P., Fuchs, S. Y., Chen, A., Wu, K.,
Gomez, C., Ronai, Z., and Pan, Z.
Q. (1999). Recruitment of a ROC1-
CUL1 ubiquitin ligase by Skp1 and
HOS to catalyze the ubiquitination
of I kappa B alpha. Mol. Cell 3,
527–533.
Tateishi,K.,Omata,M.,Tanaka,K.,and
Chiba, T. (2001). The NEDD8 sys-
tem is essential for cell cycle pro-
gression and morphogenetic path-
way in mice. J. Cell Biol. 155,
571–579.
Vaites, L. P., Lee, E. K., Lian, Z.,
Barbash, O., Roy, D., Wasik, M.,
Klein-Szanto,A.J.,Rustgi,A.K.,and
Diehl, J. A. (2011). The Fbx4 tumor
suppressor regulates cyclin D1 accu-
mulation and prevents neoplastic
transformation. Mol. Cell. Biol. 31,
4513–4523.
vanGool,A.J.,Citterio,E.,Rademakers,
S., van Os, R., Vermeulen, W., Con-
stantinou, A., Egly, J. M., Bootsma,
D., and Hoeijmakers, J. H. (1997).
The cockayne syndrome B protein,
involved in transcription-coupled
DNA repair, resides in an RNA
polymerase II-containing complex.
EMBO J. 16, 5955–5965.
Vaziri, C., Saxena, S., Jeon, Y., Lee, C.,
Murata, K., Machida, Y., Wagle, N.,
Hwang, D. S., and Dutta, A. (2003).
A p53-dependent checkpoint path-
way prevents rereplication. Mol. Cell
11, 997–1008.
Verma, R., Feldman, R. M., and
Deshaies, R. J. (1997). SIC1 is ubiq-
uitinated in vitro by a pathway
that requires CDC4, CDC34, and
cyclin/Cdk activities. Mol. Biol. Cell
8, 1427–1437.
Wang, H., Zhai, L., Xu, J., Joo, H. Y.,
Jackson,S.,Erdjument-Bromage,H.,
Tempst, P., Xiong, Y., and Zhang, Y.
(2006). Histone H3 and H4 ubiqui-
tination by the CUL4-DDB-ROC1
ubiquitin ligase facilitates cellular
response to DNA damage. Mol. Cell
22, 383–394.
Wang, T. C., Cardiff, R. D., Zukerberg,
L.,Lees,E.,Arnold,A.,and Schmidt,
E. V. (1994). Mammary hyperpla-
sia and carcinoma in MMTV-cyclin
D1 transgenic mice. Nature 369,
669–671.
Watson, I. R., Blanch, A., Lin, D. C.,
Ohh, M., and Irwin, M. S. (2006).
Mdm2-mediated NEDD8 modiﬁca-
tion of TAp73 regulates its transac-
tivation function. J. Biol. Chem. 281,
34096–34103.
Wei, N., and Deng, X. W. (2003). The
COP9 signalosome. A n n u .R e v .C e l l
Dev. Biol. 19, 261–286.
Wei, N., Serino, G., and Deng, X.
W. (2008). The COP9 signalo-
some: more than a protease. Trends
Biochem. Sci. 33, 592–600.
Willems, A. R., Lanker, S., Patton,
E. E., Craig, K. L., Nason, T. F.,
Mathias, N., Kobayashi, R., Wit-
tenberg, C., and Tyers, M. (1996).
Cdc53 targets phosphorylated G1
cyclins for degradation by the ubiq-
uitin proteolytic pathway. Cell 86,
453–463.
Wohlschlegel, J. A., Dwyer, B. T., Dhar,
S. K., Cvetic, C., Walter, J. C.,
and Dutta, A. (2000). Inhibition of
eukaryoticDNAreplicationbygem-
inin binding to Cdt1. Science 290,
2309–2312.
Wu, G., Xu, G., Schulman, B. A.,
Jeffrey, P. D., Harper, J. W., and
Pavletich, N. P. (2003). Structure
of a β-TRCP1-Skp1-β-catenin com-
plex: destruction motif binding and
lysine speciﬁcity of the SCFβ-TRCP1
ubiquitin ligase. Mol. Cell 11,
1445–1456.
Wu, K., Kovacev, J., and Pan, Z.
Q. (2010). Priming and extend-
ing: a UbcH5/Cdc34 E2 handoff
mechanism for polyubiquitination
on a SCF substrate. Mol. Cell 37,
784–796.
Wu, K., Yan, H., Fang, L., Wang, X.,
Pﬂeger, C., Jiang, X., Huang, L.,
and Pan, Z. Q. (2011). Mono-
ubiquitination drives nuclear export
of the human DCN1-like pro-
tein hDCNL1. J. Biol. Chem. 286,
34060–34070.
Xiao, Z., Chen, Z., Gunasekera, A. H.,
Sowin, T. J., Rosenberg, S. H., Fesik,
S., and Zhang, H. (2003). Chk1
mediates S and G2 arrests through
Cdc25A degradation in response
to DNA-damaging agents. J. Biol.
Chem. 278, 21767–21773.
Xirodimas, D. P., Saville, M. K., Bour-
don, J. C., Hay, R. T., and Lane, D.
P. (2004). Mdm2-mediated NEDD8
conjugation of p53 inhibits its
transcriptional activity. Cell 118,
83–97.
Xu, L., Lubkov, V., Taylor, L. J., and
Bar-Sagi, D. (2010). Feedback regu-
lation of Ras signaling by Rabex-5-
mediated ubiquitination. Curr. Biol.
20, 1372–1377.
Yan, H., Chin, M. L., Horvath, E.
A., Kane, E. A., and Pﬂeger, CM.
(2009). Impairment of ubiquity-
lation by mutation in Drosophila
E1 promotes both cell-autonomous
and non-cell-autonomous Ras-ERK
activation in vivo. J. Cell Sci. 122,
1461–1470.
Yan, H., Jahanshahi, M., Horvath, E. A.,
Liu,H.Y.,and Pﬂeger,C. M. (2010).
Rabex-5 ubiquitin ligase activity
restricts Ras signaling to establish
pathway homeostasis in Drosophila.
Curr. Biol. 20, 1378–1382.
Yang, X. H., Shiotani, B., Classon,
M., and Zou, L. (2008). Chk1
and claspin potentiate PCNA
ubiquitination. Genes Dev. 22,
1147–1152.
Yasukawa, T., Kamura, T., Kitajima, S.,
Conaway, R. C., Conaway, J. W.,
and Aso, T. (2008). Mammalian
elongin a complex mediates DNA-
damage-inducedubiquitinationand
degradation of Rpb1. EMBO J. 27,
3256–3266.
Yoon, T., Chakrabortty, A., Franks, R.,
Valli, T., Kiyokawa, H., and Ray-
chaudhuri, P. (2005). Tumor-prone
phenotype of the DDB2-deﬁcient
mice. Oncogene 24, 469–478.
Yu, Z. K., Gervais, J. L., and Zhang,
H. (1998). Human CUL-1 associates
with the SKP1/SKP2 complex and
regulates p21CIP1/WAF1 and cyclin
D proteins. Proc. Natl. Acad. Sci.
U.S.A. 95, 11324–11329.
Zhao, H., Watkins, J. L., and Piwnica-
Worms, H. (2002). Disruption of
the checkpoint kinase 1/cell divi-
sion cycle 25A pathway abrogates
ionizingradiation-inducedSandG2
checkpoints. Proc. Natl. Acad. Sci.
U.S.A. 99, 14795–14800.
Zhao,Q.,Barakat,B.M.,Qin,S.,Ray,A.,
El-Mahdy,M.A.,Wani,G.,Arafa,E.-
S.,Mir,S. N.,Wang,Q. E.,andWani,
A. A. (2008). The p38 mitogen-
activated protein kinase augments
nucleotide excision repair by medi-
ating DDB2 degradation and chro-
matin relaxation. J. Biol. Chem. 283,
32553–32561.
Zheng, J., Yang, X., Harrell, J. M.,
Ryzhikov, S., Shim, E. H., Lykke-
Andersen, K., Wei, N., Sun, H.,
Kobayashi, R., and Zhang, H.
(2002a). CAND1 binds to unneddy-
lated CUL1 and regulates the for-
mation of SCF ubiquitin E3 ligase
complex. Mol. Cell 10, 1519–1526.
Zheng, N., Schulman, B. A., Song, L.,
Miller, J. J., Jeffrey, P. D., Wang,
P., Chu, C., Koepp, D. M., Elledge,
S. J., Pagano, M., Conaway, R. C.,
Conaway, J. W., Harper, J. W., and
Pavletich,N.P.(2002b).Structureof
theCul1-Rbx1-Skp1-FboxSkp2SCF
Frontiers in Oncology | Molecular and Cellular Oncology April 2012 | Volume 2 | Article 29 | 14Li and Jin CRL and DNA damage response
ubiquitin ligase complex. Nature
416, 703–709.
Zhong, W., Feng, H., Santiago, F. E.,
and Kipreos, E. T. (2003). CUL-4
ubiquitin ligase maintains genome
stability by restraining DNA-
replication licensing. Nature 423,
885–889.
Zhu,W.,Chen,Y.,and Dutta,A. (2004).
Rereplication by depletion of gemi-
nin is seen regardless of p53 status
and activates a G2/M checkpoint.
Mol. Cell. Biol. 24, 7140–7150.
Zimmerman,E.S.,Schulman,B.A.,and
Zheng, N. (2010). Structural assem-
bly of cullin-RING ubiquitin ligase
complexes. Curr. Opin. Struct. Biol.
20, 714–721.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 08 January 2012; accepted: 10
March 2012; published online: April
2012.
Citation: Li J-M and Jin J (2012)
CRL ubiquitin ligases and DNA dam-
age response. Front. Oncol. 2:29. doi:
10.3389/fonc.2012.00029
This article was submitted to Frontiers
in Molecular and Cellular Oncology, a
specialty of Frontiers in Oncology.
Copyright © 2012 Li and Jin. This is an
open-access article distributed under the
terms of the Creative Commons Attribu-
tionNonCommercialLicense,whichper-
mits non-commercial use, distribution,
and reproduction in other forums, pro-
vided the original authors and source are
credited.
www.frontiersin.org April 2012 | Volume 2 | Article 29 | 15
09